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ABSTRACT
This article continues the series of Surveys and Sum-
maries on restriction endonucleases (REases) begun
this year in Nucleic Acids Research. Here we dis-
cuss ‘Type II’ REases, the kind used for DNA anal-
ysis and cloning. We focus on their biochemistry:
what they are, what they do, and how they do it. Type
II REases are produced by prokaryotes to combat
bacteriophages. With extreme accuracy, each recog-
nizes a particular sequence in double-stranded DNA
and cleaves at a fixed position within or nearby. The
discoveries of these enzymes in the 1970s, and of
the uses to which they could be put, have since im-
pacted every corner of the life sciences. They be-
came the enabling tools of molecular biology, ge-
netics and biotechnology, and made analysis at the
most fundamental levels routine. Hundreds of dif-
ferent REases have been discovered and are avail-
able commercially. Their genes have been cloned,
sequenced and overexpressed. Most have been char-
acterized to some extent, but few have been studied
in depth. Here, we describe the original discoveries
in this field, and the properties of the first Type II
REases investigated. We discuss the mechanisms
of sequence recognition and catalysis, and the var-
ied oligomeric modes in which Type II REases act.
We describe the surprising heterogeneity revealed
by comparisons of their sequences and structures.
PROLOGUE
We wonder what Molecular Biology would look like today
had Type II restriction enzymes not been discovered. Syn-
thesized in bewildering variety by bacteria and archaea to
combat viral infections, these enzymes allow unmanageable
tangles of macromolecular DNA to be transformed with
unsurpassable accuracy into convenient, gene-sized pieces,
a necessary first step for characterizing genomes, sequenc-
ing genes, and assembling DNA into novel genetic arrange-
ments. It seems unlikely that today’s Biomedical Sciences
and the Biotechnology industrywould have developedwith-
out Type II restriction enzymes, and certainly not at the
startling pace we have witnessed since their discovery only
a few decades ago.
INTRODUCTION
Several reviews of restriction endonucleases (REases) have
appeared as Surveys and Summaries in Nucleic Acids Re-
search recently. These concerned the somewhat esoteric
Type I (1), Type III (2) and Type IV (3) REases; highlights
of half a century of REase research and discovery (4); and
the connection between REases and genetic addiction sys-
tems (5). The present review focuses on the more familiar,
Type II REases, the ‘work horses’ (6) of modern molec-
ular biology, used daily in laboratories for DNA analysis
and gene cloning. This review is partly historical, as were
the others, and emphasizes the importance of the enzymes
EcoRI and EcoRV, among the first REases discovered,
and the two most thoroughly studied (Figure 1). It is also
partly contemporary, and provides an up-to-date overview
of the field, although one that is necessarily not compre-
hensive. Over 350 different Type II prototype REases are
known, each unique in its biochemistry, and with its own
story to tell. For most of these, anywhere from a few to
over one hundred similar enzymes from sequenced organ-
isms are known, some characterized but most putative. And
REBASE (rebase.neb.com/rebase/rebase.html), the defini-
tive source for information on REases and their compan-
ion proteins (7), lists over 8000 research publications in this
field, too many by far to be discussed here. We apologize in
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Figure 1. Number of publications for EcoRI and EcoRV per year from 1972 to 2012. Only publications are listed in which EcoRI and EcoRV are listed in
the title. Source: REBASE (7).
advance for our omissions. For a broader review of Type II
REases see Pingoud et al. (8). A comprehensive collection of
reviews on REases has been published as a book: Pingoud
(Ed.) REases (9). Two excellent additional reviews describe
early work on Type II REases by Modrich & Roberts (10)
and Roberts & Halford (11).
Following the original proposal by Smith and Nathans
(12), restriction enzymes are named according to the tax-
onomy of the organism in which they were discovered. The
first letter of the enzyme refers to the genus of the organism
and the second and third to the species. This is followed by
letters and/or numbers identifying the isolate. Roman nu-
merals are used, finally, to specify different enzymes from
the same organism. For example, the enzyme ‘HindIII’ was
discovered inHaemophilus influenzae, serotype d, and is dis-
tinct from theHindI andHindII endonucleases also present
in this bacterium. The DNA-methyltransferases (MTases)
that accompany restriction enzymes are named in the same
way, and given the prefix ‘M.’. When there is more than
one MTase, they are prefixed ‘M1.’, ‘M2.’, if they are sepa-
rate proteins and ‘M.’ or ‘M1∼M2.’ when they are joined.
REases are designated explicitly by the prefix ‘R.’; this is
usually omitted when there is no ambiguity. Enzymes in
which restriction and modification activities occur in the
same polypeptide chain are prefixed ’RM.’ (e.g. RM.BcgI),
which again is omitted when there is no ambiguity. Ad-
ditional proteins are prefixed ‘V.’ (for Vsr endonucleases)
and ‘C.’ (for control proteins). For example, the AciI R-
M system, from Arthrobacter citreus, comprises AciI (or
R.AciI), an REase; M1∼M2.AciI (or M.AciI), a compos-
ite, double MTase, and C.AciI, a control protein. REases
that recognize the same DNA sequence, regardless of where
they cut, are termed ‘isoschizomers’ (iso = equal; skhizo
= split) (13). Isoschizomers that cut the same sequence at
different positions are further termed ‘neoschizomers’ (neo
= new) (14). Isoschizomers that cut at the same position
are frequently, but not always, evolutionarily drifted ver-
sions of the same enzyme (e.g. BamHI and OkrAI). Invari-
ably, neoschizomers are different enzymes altogether (e.g.
EcoRII and MvaI).
Like the other types of restriction enzymes, Type II
REases occur exclusively in unicellular microbial life
forms––mainly bacteria and archaea (prokaryotes)––and
are thought to function primarily to protect these cells
from viruses and other infectious DNA molecules. A
group of large viruses that infect the eukaryotic algae,
Chlorella, also encode Type II REases (15,16) and DNA-
methyltransferases (MTases; (17)). The genes for Type II
REases occurmainly on chromosomes, and occasionally on
transmissible elements such as plasmids, transposons and
insertion sequences. They rarely occur on bacteriophages,
although MTases sometimes do, as one of several forms of
viral self-protection (18–20). In the discussions that follow,
we refer to all of these sources loosely, as ‘prokaryotes’, or
‘microbes’. Type IIREases aremore heterogeneous than the
other REase types in part because ‘Type II’ is a utilitarian
classification, based on enzymatic behavior rather than phy-
logeny. Type IIREases are a conglomeration ofmany differ-
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ent proteins that, by definition, have the common ability to
cleave duplex DNA at a fixed position within, or close to,
their recognition sequence. This cleavage generates repro-
ducibleDNA fragments, and predictable gel electrophoresis
patterns, properties that have made these enzymes invalu-
able reagents for laboratoryDNAmanipulation and investi-
gation. Almost all Type II REases require divalent cations–
–usually Mg2+––as essential components of their catalytic
sites. Many can use Mn2+ in place of Mg2+, and a few can
use a variety of cations includingCo2+, Zn2+,Ni2+ andCu2+
instead (21). Ca2+ ions usually, but not always, inhibit catal-
ysis. A few REases require Zn2+ ions (e.g. BslI, PacI and
DpnI (22–24)), or less oftenFe2+ ions (e.g.NotI (25)), for in-
corporation into Cys4 structural motifs. And a diverse sub-
class that catalyze DNAmethylation in addition to cleavage
(the Type IIG enzymes, discussed later) require the cofactor
S-adenosylmethionine (AdoMet or SAM), often for both
activities. Much of what we know about Type II enzymes
was discovered first with EcoRI and EcoRV. These REases
are representative of the Type IIP subclass that recognize
palindromic (symmetric) DNA sequences and generally act
as homodimers or homotetramers. Type IIP REases are the
most familiar, and the most diverse, of the several Type II
subclasses (26), but as we describe later, by no means the
only kind. See Roberts et al. (14) for the current classifica-
tion of Type II REases.
In this review, we describe some of the progress that has
been made elucidating the structures, functions and evo-
lution of Type II REases in general, and of EcoRI and
EcoRV in particular. We hope to make clear how research
on Type II REases has advanced our understanding of
protein–DNA interactions. We discuss how these proteins
locate and recognize their target sequences in DNA, how
they catalyze DNA strand cleavage, how they might have
evolved, and finally, how some are being repurposed to per-
form novel reactions for genome editing applications and
gene therapy.
Discovery of the first Type IIP restriction enzymes
The first Type II REase discovered was HindII from the
bacterium Haemophilus influenzae Rd. The event was de-
scribed by Hamilton Smith (Figure 2) in his Nobel lecture,
delivered on 8 December 1978:
‘In one such experimentwe happened to use labeledDNA
from phage P22, a bacterial virus I had worked with for
several years before coming to Hopkins. To our surprise,
we could not recover the foreign DNA from the cells. With
Meselson’s recent report in our minds, we immediately sus-
pected that it might be undergoing restriction, and our ex-
perience with viscometry told us that this would be a good
assay for such an activity. The following day, two viscome-
ters were set up, one containing P22 DNA and the other
Haemophilus DNA. Cell extract was added to each and we
began quickly takingmeasurements. As the experiment pro-
gressed, we became increasingly excited as the viscosity of
the Haemophilus DNA held steady while the P22 DNA vis-
cosity fell. We were confident that we had discovered a new
and highly active restriction enzyme. Furthermore, it ap-
peared to require onlyMg2+ as a cofactor, suggesting that it
would prove to be a simpler enzyme than that from E. coli
Figure 2. Hamilton Smith and Daniel Nathans at the Nobel Prize press
conference, 12 October 1978 (reproduced with permission from Susie
Fitzhugh). Original Repository: Alan Mason Chesney Medical Archives,
Daniel Nathans Collection.
K or B. After several false starts and many tedious hours
with our laborious, but sensitive viscometer assay, Wilcox
and I succeeded in obtaining a purified preparation of the
restriction enzyme. We next used sucrose gradient centrifu-
gation to show that the purified enzyme selectively degraded
duplex, but not single-stranded, P22 DNA to fragments av-
eraging around 100 bp in length, while Haemophilus DNA
present in the same reaction mixture was untouched. No
free nucleotides were released during the reaction, nor could
we detect any nicks in the DNA products. Thus, the enzyme
was clearly an endonuclease that produced double-strand
breaks and was specific for foreign DNA. Since the final
(limit) digestion products of foreignDNA remained large, it
seemed to us that cleavage must be site-specific. This proved
to be case and we were able to demonstrate it directly by se-
quencing the termini of the cleavage fragments.’
Isolation of Type II REases from bacterial extracts and their
use for physical mapping of DNA
Early research into the phenomenon of restriction andmod-
ification (R–M) relied on measuring how well phage in-
fected new bacterial hosts, an assay termed ‘efficiency of
plating’ (eop) performed on lawns of bacteria growing in
Petri dishes (27–29). Understanding of R–M leaped when
biochemistry was brought to bear, and modification was
shown to be the result of DNAmethylation, and restriction
the result of DNA-degradation (30). Initially, REase activi-
ties were measured by viscometry, but following the discov-
ery of the ‘Type II’ (31) kind of REases that cleave DNA at
fixed positions, further such enzymes were detected almost
exclusively by assaying cell extracts for site-specific DNA-
cleavage activity (13). This cleavage converts defined DNA
molecules such as bacteriophage  into a set of discrete frag-
ments that produce a distinct banding pattern when elec-
trophoresed through polyacrylamide (32), or agarose, gels
(33,34); see, for example (35). Visualized by ethidium bro-
mide staining of the fragments (34), gel electrophoresis in
tubes, then vertical slabs, and finally submerged horizon-
tal slabs, became a universal technique in molecular biol-
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ogy laboratories, culminating in the development of DNA
fingerprinting (36).
HindII was the first Type II REase to be characterized
(37,38) and used in this way (33), followed by EcoRI and
EcoRII from Escherichia coli (39), and several others from
Haemophilus aegypticus (40) andH. parainfluenzae (34,41).
Interestingly, unbeknownst to Smith, the first preparations
of HindII contained a second Type II REase, HindIII (42).
Its presence would have interfered severely with analysis
of the recognition sequence of HindII but for the good
fortune that phage T7 DNA––the substrate used for this
analysis––has no sites for the HindIII (43)! The pioneer-
ing work of Nathans et al. (Figure 2) (33,44–45), in which
HindII was used to physically map the genome of the tumor
virus SV40, stimulated the search for new REases with dif-
fering specificities. A prominent role in this endeavor, and
ever since, was played by Rich Roberts, who early grasped
the importance of these enzymes, and whose laboratory
at Cold Spring Harbor served as a center for their dis-
covery, characterization, cataloging and dissemination (13).
By 1978, approximately 150 Type II REases with 50 dif-
ferent sequence specificities were known, including many
‘isoschizomers’ that recognize the sameDNA sequence, and
several ‘neoschizomers’ such as SmaI and XmaI that rec-
ognize the same sequence but cleave at different positions
(46). Today, not counting putative enzymes, approximately
4000 Type II REases with over 350 different specificities
have been identified (7).
Typical purification procedures for Type II enzymes
started from a high-speed supernatant of a cell lysate,
followed by removal of nucleic acids by streptomycin or
polyethylene imine and several column chromatography
steps, using typically phosphocellulose, DEAE-cellulose,
hydroxyapatite, and gel filtration (13). Preparations were
purified to the point they were free of interfering activities,
but usually not to homogeneity. Their activity was (and still
is today) usually given in arbitrary units, namely the amount
of enzyme needed to completely digest 1 g of DNA in 1
h at optimum temperature––usually 37◦C. Because the in-
tracellular concentration of Type II REases is usually low,
often only a fewmilligrams could be isolated from kilogram
amounts of wet cell paste following a tedious end lengthy
isolation procedure.
Sequence specificities of REases and the beginning of recom-
binant DNA research
Determining the recognition sequence of a Type II REase
is a simple matter, today, but it was far from simple, ini-
tially. It required considerable experimental skill, knowl-
edge and patience as even a glance at the seminal pa-
pers makes clear (38,47–48). The first recognition se-
quence to be determined, that of HindII, was found to
be ambiguous (‘degenerate’) at the central base pair po-
sitions: 5′. . .GTPy|PuAC. . . 3′ 3′. . .CAPu|PyTG. . . .5′, or
GTY|RAC for short (where Py and Y = C or T
(pyrimidine); Pu and R = A or G (purine); and ‘|’ indicates
the position of cleavage) (38). The next, for EcoRI, was un-
ambiguous: 5′. . .G|AATTC. . . 3′ 3′. . .CTTAA|G. . . .5′, or
G|AATTC (49). And the third, for EcoRII, had a dif-
ferent ambiguity, W (A or T; weak base-pairing), at the
center: 5′. . . |CCAGG. . .3′ 3′. . . |GGTCC. . . 5′, or |CCWGG
(47,50). Phosphodiester bond cleavage in all three cases was
found to generate 5′-phosphoryl and 3′-hydroxyl terminal
groups. This has since been found to be true of all REases.
A striking feature of these three recognition sequences is
their rotational symmetry. This symmetry, it was suggested
(31), likely resulted from the subunit structure of the en-
zymes which interacted with the sequences in a symmet-
rical way. In confirmation, EcoRI was found to be com-
posed of two identical subunits, and to cleave both strands
of the DNA in one binding event, with no accumulation
of an open circle (‘nicked’) intermediate (51). Later, kinetic
experiments demonstrated that the two subunits cooperate
in binding and cleaving the palindromic substrate (52). An
important distinction between HindII and EcoRI is that
cleavage by HindII is blunt, producing fragments with flush
ends, whereas cleavage by EcoRI is staggered, producing
fragments with 4-nucleotide single-stranded overhangs, 5′-
pAATT. . . . Since these overhangs are complementary, and
all fragments have the same overhangs, they ‘. . . afford the
possibility of reconstructing DNAmolecules in vitro from any
two DNA fragments generated by RI endonuclease digestion’
(48). Mertz and Davis (53) came to the same conclusion:
‘Therefore, any two DNA molecules with RI sites can be re-
combined at their restriction sites by the sequential action
of RI endonuclease and DNA ligase to generate hybrid DNA
molecules’. It is fair to say that these insights heralded the
start of recombinant DNA research (54) and genetic engi-
neering (55) (see reflections by Berg and Mertz (56), and by
Cohen (57)).
Effect of sequences flanking the recognition site on the cleav-
age activity of REases. Early studies on EcoRI focused on
the cleavage of plasmid and phageDNAmolecules. The rate
at which EcoRI cleaved EcoRI sites was shown to depend
upon flanking sequences (58–61). Later, this was systemati-
cally analyzed with synthetic oligonucleotides (62,63). Sim-
ilar studies were carried out with other REases, including
EcoRV (64). Not unexpectedly, it was found that flanking
sequences in general modulate the thermodynamic and ki-
netic parameters of the interaction between REases and
their targets. EcoRI, for example, interacts symmetrically
with a minimum of 10 nucleotide pairs (65), which ac-
counts in part for why it cleaves the 8 bp oligonucleotide,
TGAATTCA, 200 times less efficiently than the equivalent
natural site in SV40 DNA (66). The conformation of the
DNA of the recognition sequence is also influenced by the
surrounding sequence (67), which might also affect the rate
of DNA cleavage by REases. Using a selection assay, vari-
ants of EcoRI were isolated that differed from the wild-type
enzyme in their preference for flanking sequences (68). Simi-
larly, EcoRV variants with different flanking sequence pref-
erences could be engineered by a structure-guided design
(69).
Star activity and the accuracy of REases. At low ionic
strength and alkaline pH, EcoRI was found to cleave DNA
at additional sites, typically N/AATTN (70). This ‘star ac-
tivity’ (EcoRI*) was also observed in the presence of or-
ganic solvents, such as glycerol or DMSO (71–73), and
when Mg2+ is replaced by Mn2+ (74). Co2+ and Zn2+ also
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support DNA cleavage, but unlike Mn2+ do not result
in star activity (75). Preferred EcoRI* sites were identi-
fied to be GGATTT, AAATTT, GAATTT and GAATTA,
whereas CAATTG resists attack (73). Later, Rosenberg and
Greene (76) suggested that the hydrolysis rates of EcoRI*
sites can be summarized by the hierarchies: G>>A>T>>C
at the first position, and A>>[G,C]>>T at the second and
third positions (and the corresponding complements at po-
sitions four, five and six). This was later quantitatively an-
alyzed with synthetic oligonucleotides (77). Star activity
turns out to be a general phenomenon, observed with other
REases (e.g. 72,78–83).
Star activity is often also observed at high enzyme con-
centrations under optimum buffer conditions, and this re-
flects the finite accuracy of these enzymes. By analyzing the
rate of cleavage of star sites on a plasmid DNA by EcoRV
it was possible to estimate the accuracy of a REase. The
plasmid pAT153 contains 12 EcoRV* sites, each of which
differs from the wild-type EcoRV sequence (GATATC) by
one base pair. EcoRV showed a marked preference for one
of these sites (GTTATC), which was cleaved (kcat/Km) six
orders of magnitude more slowly than the cognate site
(GATATC). Nicked intermediate accumulates in the course
of this cleavage. In vivo, this would enable DNA ligase
to repair the single-strand breaks that arise at star sites
(84). From cleavage studies with oligonucleotides, it was
concluded that double-strand cleavage of non-cognate sub-
strates is at least five orders of magnitude slower than cleav-
age of the cognate substrate (85). While in the cognate sub-
strate both strands of the DNA duplex are cleaved at the
same rate, in non-cognate substrates one strand is cleaved
faster than the other one. These studies showed that REases
are among the most accurate enzymes known. This high
accuracy is achieved by both preferential binding (ground
state) and preferential catalysis (transition state). Cleavage
at star sites by high concentrations of enzyme can be sup-
pressed to some extent by spermidine (86), hydrostatic pres-
sure (87) and, as shown recently, by mutations (88).
The structural basis of specificity of REases: characteriza-
tion of the REase–DNA interface using modified substrates.
Because Type II REases recognize their substrate sequences
so accurately, they are attractive subjects for studying the
mechanism of recognition. It was unclear at the begin-
ning of these studies how recognition occurred, and it re-
mains incompletely understood today. Initially, it was spec-
ulated that recognition of symmetric (‘palindromic’) se-
quences might depend on unusual structures such as open,
partially single-stranded, sequences (38) or cruciforms (89).
Although DNA is almost always distorted to some degree
when bound by REases, these deformations are thermody-
namically unstable, and aside from a few unusual occur-
rences in recently solved crystal structures (e.g. PacI (22),
and the EcoRII/PspGI/Ecl18kI/SsoII family (90)), they
play little role in sequence recognition.
A decade before the first REase-DNA co-crystal struc-
ture (EcoRI) was solved, it was realized that in the DNA
double helix, each base pair offers a unique pattern of
contacts in the major and minor grooves that might en-
able base-recognition by ‘direct readout’, and also, per-
haps, through additional contacts to backbone phosphate
groups by ‘indirect readout’ (i.e. the recognition of a DNA
sequence through the sequence-dependent conformation
of the DNA backbone). X-ray crystallography of double-
stranded RNA molecules, in conjunction with a systematic
analysis of possible amino acid–base contacts, suggested
that proteins might discriminate base pairs by the positions
and polarities of hydrogen bonds (H-bonds) (91). From
an experimental point of view, DNA molecules contain-
ing modified bases can be used to identify features within
recognition sequences, such as H-bond donors and accep-
tors, or thymine 5-methyl groups, that REases might use for
recognition. Disruption of such interactions by nucleotide
methylation is the universal way that cells protect their own
DNA from REase cleavage, naturally. Methylation of the
EcoRI recognition sequence by the M.EcoRI methyltrans-
ferase (MTase), for example, changes the sequence from
GAATTC toGAm6ATTC (m6A=N6-methyladenine) and
this ‘modification’ completely protects the sequence from
cleavage by EcoRI (48,92).
Analysis of naturally modified DNA molecules allowed
some of the features of GAATTC that are important to
recognition by EcoRI to be discerned. Non-glucosylated
bacteriophage T4 DNA is cleaved partially by EcoRI, in-
dicating that 5-hydroxymethylcytosine (5hmC) can be ac-
cepted instead of cytosine in GAATTC (93–95). Substi-
tuting hydroxymethyluracil (hmdU) for thymine lowers the
maximal velocity of cleavage (Vmax) somewhat, but does not
affect Km; substituting uracil (dU) instead affects neither
Vmax nor Km (96). These results suggest that the 5-methyl
groups of thymine are not major determinants for recog-
nition by EcoRI. Substituting inosine for guanine likewise
suggested that the minor groove 2-amino group of dG also
does not play an important role in recognition by EcoRI in
contrast to what was found for M.EcoRI (97). This implies
that the recognition mechanism of the REase and its com-
panion MTase differs, a situation now known to be true for
all such pairs since they display little amino acid sequence
similarity and frequently bind in different oligomeric forms,
the one as a homodimer, for example, and the other as a
monomer.
Synthetic oligodeoxyribonucleotides (oligos) became
available In the early nineteen-seventies; solid phase synthe-
sis was introduced somewhat later (98). The first cleavage
experiment with EcoRI and synthetic oligos was performed
with the self-complementary 8-mer pTGAATTCA, which
was accepted as a substrate by both R.EcoRI andM.EcoRI
(66). Oligos were subsequently used extensively to study
structure–function relationships in the recognition process
of EcoRI and other REases (77,99–110). Using oligos with
modified bases, recognition of the same sequence by differ-
ent enzymes could be analyzed and compared. For example,
the thymine residues (probed by dU, hmdU and BrdU) in
the EcoRI recognition sequence (GAATTC) appear not to
be directly involved in the recognition process by R.EcoRI,
whereas they are important for M.EcoRI (96), and they are
major points of contact for R.EcoRV (101). Similarly, it was
shown that the isoschizomers HaeIII, BspRI and BsuRI,
which recognize and cleave the same sequence, GG|CC, do
so in different ways. Substituting dI for dG, and dU for dC,
within the recognition site affected the rates of cleavage dif-
ferently for all three enzymes (111).
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Figure 3. Schematic illustration of the steps involved in DNA recognition
and cleavage by REases (120).
Modified oligos were also important in analyzing the
mechanistic and stereochemical aspects of catalysis by
EcoRI (112–114) and EcoRV (115,116). In the words of a
much respected pioneer in this field, through such experi-
ments it was ‘possible to discern the topography of the active
sites of enzymes by examining substrate analogs for their abil-
ity to serve as reactants. Such investigations aim to contribute
to our understanding of the kinetic and chemical mechanisms
as well as the stereochemistry and stereoselectivity of a reac-
tion’ (117).
In a complementary approach, alkylation-protection,
ethylation-interference, chemical-crosslinking, and UV-
and chemical-footprinting experiments were carried out to
probe the EcoRI–DNA interface (65,109,118–119). They
showed that EcoRI protected the major groove N7 atom
of dG, and the minor groove N3 atom of both dA residues
within the EcoRI sequence against methylation by dimethyl
sulfate. Ethylation-interference experiments showed that all
but one of the phosphates within the recognition sequence,
when alkylated, interfered with complex formation, and
that two additional phosphates on each side of the recog-
nition sequence also contacted the enzyme. The base and
phosphate contacts were found to be symmetrically dis-
tributed about the dyad axis of the EcoRI sequence, demon-
strating that the EcoRI dimer interacts with both strands of
the EcoRI sequence equally.
Biochemical characterization of REases
The catalytic reaction of a REase entails the following pro-
cesses (Figure 3): (i) attaching to DNA non-specifically; (ii)
locating the target sequence; (iii) recognizing and binding
that sequence; (iv) coupling of recognition and catalysis; (v)
cleavage of the sequence; and (vi) product release.
Steady-state kinetics. The first REase purified to homo-
geneity and rigorously characterized was EcoRI (121),
which recognizes G|AATTC in double-stranded DNA and
cleaves in the presence of Mg2+ ions at the position (‘|’)
indicated (48,53). Its subunit molecular weight was deter-
mined to be around 30 kDa (122). In solution it exists
in dimer–tetramer equilibrium with a Kd of 0.1 M. Its
Michaelis-Menten parameters toward ColE1 DNA at 37◦C
were found to be kcat = 4 min−1 and Km = 8 nM (121). In
single-turnover experiments at high EcoRI concentrations,
the catalytic constant for cleavage of each strand had the
same value of 0.35 s−1 at 21◦C (123). These data suggest
that product release is rate limiting for EcoRI cleavage of
macromolecular DNA substrates. The reason for this may
be that the preferred way of dissociation of enzyme and
product involves outside sequences (see below). Similar bio-
chemical properties were described later for other Type II
REases, particularly those of the Type IIP subclass (124–
126), although in some cases, most notably for Type IIT
REases (127,128), the two strands are not cleaved simulta-
neously, and nicked intermediate can accumulate (126,129).
Yet other Type IIP REases are monomers that cleave the
two DNA strands sequentially, one after the other, in sepa-
rate catalytic events (130–133).
Thermodynamics and kinetics of DNA binding. The affin-
ity of a REase for its substrate sequence was determined
for EcoRI using the nitrocellulose filter-binding technique
that had been developed in the mid-1960s (134,135). Exper-
iments with EcoRI, and with other REases, were carried
out in the absence of Mg2+ to prevent cleavage (see (136–
139) for early reviews). At 37◦C, affinity to pBR322 (with
one EcoRI site) decreases with increasing ionic strength: at
0.07–0.15M,Kd lies between 10−11 and 10−10 M (139).With
 DNA (with one EcoRI site) a Kd of 10−9 M was deter-
mined at 22◦C and an ionic strength of 150 mM (138). The
parameter measured in these experiments is an apparent
Kd, as it does not take into consideration that non-specific
DNA binding accompanies specific binding. Using a pro-
tection assay, the Kd for non-specific binding of EcoRI to
X174 DNA (with no EcoRI sites) was determined to be
in the range of 10−6 M (nucleotides) at an ionic strength
of 200 mM and at 20◦C (140). Non-specific binding was
also analyzed by a competition-cleavage assay with syn-
thetic polynucleotides in the presence of Mg2+ and the Kd
was found to be 10−4–10−5 M (nucleotides) (141). Strong
specific binding in the nM to pM range, and relatively weak
non-specific binding in the M range, was found to be true
of REases in general. While EcoRI and most other Type II
REases bind to their recognition sequence specifically even
in the absence of Mg2+, EcoRV binds all DNA sequences
with equal affinity in the absence of Mg2+ (142). As was
shown by the newly developed gel electrophoretic mobil-
ity shift assay (143,144), Mg2+ and other divalent metal
ions, particularly Ca2+, confer specific binding ability on
EcoRV (145). Today, this assay (‘EMSA’) has largely re-
placed the nitrocellulose filter binding technique for ana-
lyzing the binding of proteins to nucleic acids.
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Formation of the non-specific complex and transition to
the specific complex is accompanied by changes in solva-
tion and counter-ion binding. For EcoRI, the non-specific
complex was found to sequester around 110 more water
molecules than does the specific complex with the recogni-
tion sequence (146). This indicates that the association be-
tween the protein and the DNA is much tighter in the spe-
cific complex than in the non-specific complex, with only
a small number of water molecules present at the protein–
DNA interface.
Facilitated diffusion, linear diffusion, sliding and hopping.
Detailed investigation of the kinetics of theEcoRI-substrate
interaction revealed a surprising result (10,147). Whereas
the affinity, Kd, of EcoRI to pBR322, a 34 bp oligo derived
from pBR322 containing one EcoRI recognition site, and
the double-stranded dodecamer p(CGCGAATTCGCG)
varied between 5 × 10−12 and 15 × 10−12 M, the dissoci-
ation rate constants, kd, for complexes of EcoRI and DNA
weremuchmore dependent on the chain length of the DNA
(148). This led Modrich et al. to conclude that outside
DNA sequences are involved in the major kinetic path by
which EcoRI locates and leaves its recognition sequence
(148). This was interpreted in terms of facilitated diffusion
(149,150), meaning that EcoRI locates its recognition se-
quence by first binding to DNA non-specifically, and then
sliding along the DNA randomly until it encounters the se-
quence. Likewise, EcoRI leaves its recognition site, to which
it binds firmly, via non-specific sliding. Facilitated diffusion
is also observed in the presence of Mg2+, as shown by ana-
lyzing the DNA cleavage-rate dependence for substrates of
different length (148). It was shown that the mean diffusion
length of EcoRI is approximately 1000 bp at 1 mMMgCl2;
similar results were obtained for HindIII and BamHI (151),
and later confirmed for BamHI (152), and demonstrated by
different techniques for EcoRV (153,154) and BssHII (155).
Linear diffusion is critically dependent on contacts be-
tween amino acid side chains of the protein and the back-
bone of the DNA. Changing the centro-symmetric electro-
static potential in the DNA-binding site affects sliding. It
was demonstrated that the presence of other proteins bound
to the DNA, and of irregular DNA structures such as bent
DNAor a triple helix, constitute a barrier that cannot easily
be passed by EcoRI (151,154). Although DNA in the cell is
packed with other proteins, facilitated diffusion is still es-
sential for in vivo function, as shown for EcoRV by corre-
lating the phage restriction activity and the linear diffusion
rate of EcoRV variants (156). Sliding of REases is likely to
follow the pitch of the double helix. This was experimentally
verified for EcoRV. The enzyme tends to overlook cleavage
sites at 1 mM MgCl2 (which could be the consequence of
hopping) but not at 10 mMMgCl2, which indicates that un-
der these conditions sliding predominates (153).
Themechanisms of facilitated diffusion have been of con-
tinuous interest to the present day. As pointed out by Mod-
rich et al. (147), facilitated diffusion ofREases could involve
one-dimensional sliding as well as hopping, as originally
proposed (149). For some REases it has been argued that
the principal mode of transfer is by ‘hopping’ and ‘jump-
ing’, i.e. the dissociation of the protein from one site fol-
lowed by its re-association with another site in the same
DNA molecule, either close to or distant from the origi-
nal site (157). There are a variety of ways to analyze facili-
tated diffusion of REases and its contribution to target lo-
cation (158,159). Single-molecule experiments are particu-
larly useful for this purpose and substantiate that sliding al-
ternates with hopping/jumping during facilitated diffusion
of EcoRV (160,161). The extent to which REases make use
of one-dimensional or three-dimensional diffusion for tar-
get site location depends on the ionic strength and theMg2+
concentration (153). The actual path length for sliding, and
the effect of salt on this process, are likely to vary from pro-
tein to protein (162).
Cloning and sequencing of the genes coding for REases
Five years after EcoRIwas purified to homogeneity in 1976,
the amino acid sequences of the EcoRI REase and MTase
were determined by cloning the EcoRI R–M system and
sequencing its two genes (163,164). R.EcoRI was found to
comprise 2 × 277 amino acids (subunit molecular mass,Mr
= 31,063 Da), and M.EcoRI to comprise 1 × 326 aa (Mr
= 38,048 Da). 31 kDa is a typical subunit size for a Type
IIP REase, which ranges in size from PvuII (recognition se-
quence: CAG|CTG; subunitMr = 18.3 kDa), on the small
side, to ClaI (AT|CGAT; subunit Mr = 41.6 kDa), on the
large side. No aa sequence similarity was found between the
EcoRI REase and MTase, even though they recognize the
same DNA sequence, suggesting that the two proteins had
different evolutionary origins (164). Lack of similarity be-
tween REases and their companion modification enzymes
has since been found to be true for all R–M systems of this
kind, suggesting that R–M systems arose by gene associa-
tions rather than by gene duplications and divergence.
Following the cloning of EcoRI, the genes of many more
Type II REases were cloned, sequenced and compared.
Cloning brought many benefits. Genes could be moved
from poorly characterized organisms to more convenient
hosts such as E. coli K12. They could be sequenced, stud-
ied and altered. Their proteins could be separated from
contaminating enzymes present in the original host. And,
by increasing gene copy number and expression rates, they
could be produced in greater quantities. Molecular biolo-
gists were quick to apply gene cloning to the very enzymes
that made cloning possible, including DNA ligases (165–
168), DNA polymerases (169,170) and restriction enzymes;
see (171,172) for early reviews. Almost all of the enzymes
available commercially today for DNA manipulation and
analysis––including over 250 REases––are purified from
overexpression clones. As a result, these reagents are much
purer and less expensive than they were, and in the process
a great deal has been learned about their biology, genetics
and biochemistry. Perhaps no other class of enzymes has
been investigated as extensively as Type II REases.
Cloning REases presents several challenges. Foremost is
their toxicity. Cells protect themselves from restriction by
methylating each recognition site in their own DNA. This
‘modification’ is catalyzed by the MTase(s) that partner
with restriction enzymes in vivo to form R–M systems. In
order to clone an REase, its partner MTase(s)––there can
be more than one––must also be cloned to prevent destruc-
tion of the new host’s DNA. Fortunately, perhaps due to
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eons of natural selection for efficient lateral gene transfer
between prokaryotes, the genes for the REase and its ac-
companying MTase(s) are usually closely linked. This al-
lowed many R–M systems to be cloned in one step, on
DNA fragments that contained both genes. Among these
were HhaII (173,174), EcoRII (175,176), EcoRI (164,177),
PstI (178,179), PaeR7I (180–182), EcoRV (183,184), PvuII
(185) and BsuRI (186). Some of these systems occurred
on plasmids and were isolated by simple sub-cloning. Oth-
ers were chromosomal, and were isolated by selecting for
phage-resistance, for insensitivity to restriction (187) or for
resistance toREase-digestion (188). See (189) for a brief dis-
cussion of early cloning methods.
When R–M systems are cloned, the recipient cell can be
exposed to the new REase before its DNA becomes fully
modified. Cells can cope with this in some cases (18), but in
others they cannot, and when this occurs the system must
be cloned in two steps. The MTase gene must be cloned
first, and the cells allowed to become fully modified before
the REase gene is introduced on a separate vector. DdeI
(190), BamHI (191) and BglII (192) were early examples
of this situation. In addition to genes encoding the REase
andMTase(s), manyR-M systems include a gene for a ‘con-
troller’ protein. These C-proteins are transcriptional regula-
tors that are thought to coordinate gene expression during
natural lateral transfers to avoid premature REase synthesis
(193–196).
Another challenge to cloning R-M systems concerns the
MTases themselves. Some strains of E. coli cannot tolerate
certain kinds of DNA methylation. MTases that catalyze
such modifications, and the R-M systems to which they
belong, cannot be transformed into these hosts, whereas
they can into other strains such as HB101 and its deriva-
tive, RR1 (197–199). This intolerance was traced to two
endogenous E. coli systems, termed RglA and RglB, first
encountered in connection with the restriction of non-
glucosylated bacteriophage T4 (200). The DNA of this
phage contains 5hmC instead of cytosine, and the Rgl sys-
tems were thought to attack 5hmC-containing DNA, exclu-
sively. In fact, it was found, they also attack DNA contain-
ing 5-methylcytosine (5mC) in certain sequence contexts,
and since 5mC-modification is catalyzed bymanyR–M sys-
tems, these systems are incompatible with Rgl-proficient
cells.
The Rgl systems were renamedMcrA (modified cytosine
restriction) andMcrB (later McrBC) to more accurately re-
flect their specificities (198,201). McrA restricts modified
DNA in the context of the HpaII recognition sequence,
C5(h)mCGG. It is a small HNH-type endonuclease (202–
204)), but has not been well characterized. McrBC restricts
modified DNA in the context R5(h)mC (R = A or G)
and is well characterized. These enzymes are examples of
a growing collection of ‘modification-dependent’ REases,
now termed ‘Type IV’, that includes Mrr (205–207), MspJI
(208), PvuRts1I (209–212), GmrSD (213) and BisI (214),
which we are learning are ubiquitous in bacteria. See (3) for
a recent review.
Scientific progress depends on insight and careful experi-
mentation and also sometimes, as Mcr exemplifies, on plain
good luck (43). HB101/RR1 and K802 were popular E.
coli cloning hosts at the time and were used for most of
the early R-M cloning experiments. As was eventually dis-
covered, HB101/RR1 is defective in McrBC and Mrr, and
K802 is defective in McrBC and McrA (206). The fortu-
itous choice of these hosts allowed many R-M systems to
be cloned, and thence the existence of the Mcr systems to
be discovered. Had alternative popular cloning hosts of the
time been used instead, such as MM294 (McrA+, McrBC+,
Mrr+), attempts to clone R–M systems would frequently
havemet with failure, and this would have set the effort back
considerably.
Several procedures were used to clone Type II R–M sys-
tems. The customary starting point was a plasmid library
containing partial-digestion fragments of total bacterial or
archaeal DNA (Supplementary Figure S1). The libraries
were grown to allow plasmids carrying MTase genes to
modify themselves. The plasmid pools were purified, and
then digested in vitro with the REase whose gene was to be
cloned in order to destroy unmodified plasmids, but leave
modified plasmids intact. The digests were re-transformed,
and survivors were screened individually, or pooled and cy-
cled through another round of selective REase-digestion.
This procedure, termed ‘methylase-selection’ or, whimsi-
cally, ‘the Hungarian trick’ (189), is a more general ver-
sion of the method used to clone the first MTase, M.EcoKI
(187). It was suggested byMann et al. as a possible alterna-
tive to the phage-resistance method that they used to clone
HhaII (174). The procedure reliably yields MTase genes, it
was found (188,215–217), but often not complete R–M sys-
tems.
Libraries were also exposed to phages to select for cells
able to restrict because they carried complete R–M sys-
tems (178). This ‘phage-selection’ method frequently failed,
however, likely due to inadequate R-gene expression (218).
When methylase-selection yielded only the M gene, ad-
jacent overlapping fragments were identified by Southern
blots, mapping, inverse PCR and sequencing, in order to
obtain the R gene. N-terminal amino acid analysis of pu-
rified REases, and internal tryptic peptide analysis, were
often used to identify the correct open reading frame. Be-
tween 1980 and 2005, several hundred Type II R–M sys-
tems were cloned and analyzed, some in academic labora-
tories, but most in the research laboratories at New Eng-
land Biolabs (NEB) in the United States, and at Fermentas
(now part of Thermo Fisher Scientific) in Lithuania. Since
then, with the advent of inexpensive genome sequencing us-
ing 454 Life Sciences machines (Roche), and more recently
PacBio single-molecule real-time (SMRT R©) machines (Pa-
cific Biosciences), many R–M systems have been cloned by
identifying their genes through bioinformatics analysis of
whole-genome sequences, and then retrieving them by PCR
or by gene synthesis. PacBio offers an advantage in this
regard because it not only generates the DNA sequences
of the R–M systems present but also, through methylome
analysis, often the recognition sequences of those same sys-
tems (219).
As information about the organizations, genes and pro-
teins of R–M systems accumulated as a result of cloning, an
online dedicated database was created by Rich Roberts and
Dana Macelis with funding from the National Library of
Medicine (220). REBASE has been continuously improved
over the years and is updated almost daily with new data
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on R–M systems of all types including putative systems
identified in genomic sequences by bioinformatics analy-
sis, and very recently, with PacBio methylome information.
Despite its folksy homepage, REBASE (http://rebase.neb.
com/rebase/rebase.html) is an encyclopedic source of expert
knowledge on all things related to restriction and modifica-
tion (7). Most of the R–M systems that have been cloned
and characterized have not been formally published. Their
sequences are nevertheless available in REBASE, for the
most part, and when they are not, they can be provided
upon request. A list of the R-M systems cloned by various
groups at NEB is given in Supplementary Table S1.
Evolution of Type II REases
Except for isoschizomers, Type II REases were found to
share surprisingly little aa sequence similarity. This led
many researchers to believe that, for the most part, they
are not evolutionarily related. One of the earliest exam-
ples of clear aa sequence similarity between REases was
found between EcoRI and RsrI, which catalyze the same
reaction: G|AATTC (221). The aa sequences of these two
enzymes are identical in several places and 50% identical
overall (222). It was perhaps not surprising, then, that cat-
alytically active hybrids of these two isoschizomers could
be formed (223). A common evolutionary origin seems in-
disputable for these two enzymes, as it also does for other
pairs of isoschizomers such as MthTI, NgoPII and FnuDI
(224), and XmaI and Cfr9I (171,225). A systematic sta-
tistical analysis of the phenotype (substrate composition,
length and cleavage position) of REases on one hand and
the genotype (amino acid sequence) on the other (226) sug-
gested that REases of the PD. . . .D/EXK family are fre-
quently the products of divergent evolution. Furthermore,
comparison of codon usage among REases and their com-
panion MTases (227) indicated that horizontal gene trans-
fer has contributed to the wide distribution and evolution
of Type II R–M systems in general. Ichizo Kobayashi and
colleagues at Tokyo University have shown that R–M sys-
tems can act as selfish genetic elements and that this might
have contributed to the evolution of R–M gene pairs (228).
The notion that apparently disparate REases might nev-
ertheless be evolutionarily related, in some instances, grew
more compelling when crystal structures of REases became
available and revealed that the catalytic site for DNA cleav-
age (‘the common core’) was structurally similar in many
of them (229–231). Multiple alignments of REase aa se-
quences sometimes shows sequence similarities over short
stretches of a few amino acids, likewise suggestive of per-
haps common, if distant, evolutionary origin (232–234).
BfiI (235) was the first REase found that did not belong to
the PD. . .D/EXK catalytic family; it belongs to the phos-
pholipase D superfamily (236) instead and, unique among
REases, does not require a divalent metal ion such as Mg2+
for cleavage. There is clear evidence from bioinformatics
and structural studies that several other Type II REases
do not belong to the PD. . .D/EXK family, either. KpnI
(GGTAC|C) (237), Hpy99I (|CGWCG) (238) and PacI
(TTAAT|TAA) (22) belong to the ‘HNH’-endonuclease
family that includesHolliday junction resolvases. (These are
also referred to as ‘beta beta alpha-metal fold’ REases due
to the presence of Cys4 Zn2+-binding structural elements.)
Eco29kI and Cfr42I (CCGC|GG) (21,239), and Hpy188I
(TCN|GA) (240,241) belong to the ‘GIY-YIG’-family that
also includes many homing endonucleases (233,242). We
discuss these catalytic classes briefly later. Type II REases
are currently grouped into several subtypes. These sub-
types do not necessarily represent separate branches on
the REase evolutionary tree. For example, SsoII (Type IIP;
|CCNGG), EcoRII (Type IIE; |CCWGG) and NgoMIV
(Type IIF; G|CCGGC) have remarkably similar DNA-
binding sites and catalytic centers (234). Specificities for
partly related, and even unrelated, sequences can neverthe-
less depend upon the same structural framework: CCNGG
(SsoII), CCWGG (PspGI/EcoRII), GCCGGC (NgoMIV),
RCCGGY (Cfr10I), GATC (MboI) (243).
Large-scale purification of REases from overproducing E.
coli strains
Overproduction of EcoRI, EcoRV and other REases was
of great importance for the biochemical study of these en-
zymes. EcoRI, for example, could be isolated in gram quan-
tities from an overproducing strain rather than milligram
quantities from the wild-type bacterium (244). In some con-
structs (245), overproduction of EcoRI resulted in inclusion
body formation. EcoRV overproduction yielded a soluble
protein preparation (183). Introduction of polyhistidine-
tags at the N-terminus or C-terminus of recombinant
REases enabled rapid, small-scale partial-purifications by
metal chelate chromatography (246) and increased the
speed with which REases and their engineered derivatives
could be isolated and purified manyfold. Overproduction
was, in many cases, the prerequisite for a crystallographic
analysis.
Crystal structures of REases in complex with DNA
The first REase crystal structure, that of EcoRI, was re-
ported in 1986 (247). The enzyme was crystallized with self-
complementary 12- and 13-mer oligos in the absence of
Mg2+ to avoid DNA cleavage. Although the 3 A˚ resolution
of the structure was low by today’s standards, it represented
the first detailed picture of a protein interacting with its
recognition sequence at the atomic level. This structure gen-
erated intense interest (247) and immediately sparked site-
directed mutagenesis experiments aimed at studying these
interactions. The methodology of site-directed mutagene-
sis had been developed by Smith et al. a few years earlier
(248). Mutational analysis was carried out both to verify
the proposed recognition and cleavage mechanisms, and to
rationally alter the sequence specificity of EcoRI, if pos-
sible, by changing the amino acids that form its binding
site (249–257). The results of these experiments contra-
dicted some aspects of the structure, prompting this to be
re-examined, and subsequently revised (258). Over the next
decade, the co-crystal structures of six more Type II REases
bound to their recognition sequences were solved to increas-
ingly higher resolution. These included EcoRV (259), PvuII
(260), BamHI (261), FokI (262), BglI (263) andMunI (264)
(Figure 4). Over 30 REase-DNA co-crystal structures have
now been solved and represent a substantial, if underused,
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Figure 4. Co-crystal structures of specific restriction enzyme–DNA complexes determined between 1990 and 1999.
collection of material for further study (Supplementary Ta-
ble S2).
Comparison of the EcoRI and EcoRV co-crystal
structures, and structure-guided site-directed mutagenesis,
showed that the two enzymes had similar PD-(D/E)XK
active sites (265,266), and similar overall folds compris-
ing -sheets sandwiched between -helices (231). This fold,
a central, four-stranded mixed -sheet flanked by two -
helices on both sides (with  topology), was subse-
quently found, with variations, (267,268) in almost all Type
II REases whose structures have been determined. This fold
is classified in the SCOP (Structural Classification of Pro-
teins) database [http://scop.mrc-lmb.cam.ac.uk/scop] as the
REase-like fold. Recent bioinformatics analysis (26) indi-
cated that among 289 experimentally characterized Type II
REases, whose full-length sequences were available, 69% be-
longed to the PD-D/EXK phosphodiesterase superfamily
that includes other nucleases such as -exonuclease, RecB
endonuclease, Sulfolobus solfataricus Holliday junction re-
solvase, MutH, T7 endonuclease I, and VSR endonuclease.
The recognition process as deduced from co-crystal structures
The crystal structures of specific complexes formed between
REases and oligos containing their recognition sequence
are presumed to be representative of the recognition event,
even though the essential metal cofactorMg2+ is usually ab-
sent or substituted by the catalytically inactive Ca2+ orNa+.
In most structures, the boundDNA is distorted to some de-
gree from B-form DNA, and in some––MspI, for example
(269), and PacI (22)––changes seem to have occurred dur-
ing crystallization that obscure the recognition event. Nev-
ertheless, REase co-crystal structures are the basis for our
efforts to understand the recognition process. It should be
kept in mind that at best these give only a snapshot of what
is a dynamic process, and only an idea of what the transi-
tion state looks like. The recognition process begins with
complex formation, and ends with the catalytic action.
EcoRI. Upon specific complex formation with EcoRI, the
DNA becomes kinked and unwound within the AATT se-
quence. The two central base pairs of GAATTC are un-
stacked and wedged 55◦ apart by insertion from the ma-
jor groove of the Ala 142 side chain methyl group from
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Figure 5. Schematic representation of the interaction of EcoRI with its
recognition sequence. For clarity, interactions with only one subunit are
shown; those with the other subunit are identical and symmetric. Hydro-
gen bonds and polar interactions are shown as arrows, van derWaals inter-
actions as dotted lines. Amino acids and interactions involved in catalysis
are depicted in red; those involved with sequence-recognition are depicted
in green and blue (120).
each subunit, which also widens the major groove. Overall,
the DNA is bent by about 12◦. Facilitated distortion of the
DNA site enhances EcoRI–DNA recognition, a subtlety
of the recognition mechanism true for many other REases
(114). The central distortion of EcoRI, for example, nudges
the adjacent AT and TA base pairs there into better align-
ment with the side chain of Arg 145, and the main chain
atoms of Asn 141 and Ala 142 with which they form H-
bonds. Several structural elements of EcoRI are involved
in DNA contacts (Figure 5): (i) a bundle of four -helices,
two from each subunit, penetrate the widened major groove
and make base and backbone contacts at their amino ter-
mini; (ii) an extended chain runs through the major groove
of the recognition site; (iii) a -strand running parallel to
the DNA backbone contains amino acid residues essen-
tial for catalysis and amino acid residues engaged in phos-
phate contacts; (iv) two arms reach around the DNA and
are responsible for backbone contacts outside of the recog-
nition sequence. These contacts outside of the recognition
sequence may explain why EcoRI cleaves its sites on DNA
with different rates depending on the adjacent sequences
(58–59,62–63).
Figure 6. Schematic representation of the interaction of EcoRV with its
recognition sequence. Interactions with only one subunit are shown; those
with the other subunit are identical and symmetric. Amino acids and in-
teractions involved in catalysis are depicted in red; those involved with
sequence-recognition are depicted in green and blue (120).
Altogether, there are 16 protein-base H-bonds (12 to
purines and 4 to pyrimidines), and 6 van der Waal’s
contacts (to the pyrimidines), all in the major DNA
groove. In addition to these base-specific contacts (‘direct
readout’), there are numerous contacts to the backbone
of the DNA that could recognize the specific sequence
through sequence-dependent backbone conformation (‘in-
direct readout’) (270). These contacts play a very impor-
tant role in coupling recognition to catalysis and in co-
ordinating the two catalytic sites (271). Thus, the recog-
nition process is redundant, with multiple direct and/or
indirect contacts to each base pair. Many of these con-
tacts were probed by site-directed mutagenesis experiments,
which have confirmed their importance for the recogni-
tion process (249,254–256,272–277). In general, mutation
of amino acids involved in base-specific contact results in
a large reduction in activity, but not to a change in speci-
ficity. That these contacts can be removed without reducing
the accuracy of discrimination indicates that the recognition
process is highly redundant, and might also depend upon
steric exclusion and structural factors of the kind referred to
as ‘appositional interactions’ (278,279). It must be empha-
sized that a mutational analysis of the protein–DNA con-
tacts is at best qualitative because amino acid substitutions
inevitably perturb the protein structure, and likely also al-
ter the arrangement of watermolecules at the protein–DNA
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interface. Specific complex formation was analyzed by fast
kinetics. EcoRI and the substrate were found to associate in
the presence of Mg2+ in a nearly diffusion-controlled pro-
cess (280).
EcoRV. The structure of EcoRV, the next to be crystal-
lized after EcoRI, was solved in multiple forms, including
the free enzyme (apo-protein), specific enzyme–DNA com-
plexes, an enzyme–product complex and, revealingly, a non-
specific complex (259,281). BamHI is the only other REase
for which such a range of structures is available (261,282).
Comparison of the non-specific and the specific EcoRV
complexes reveals the conformational changes that accom-
pany recognition. EcoRV induces a striking distortion from
regular B-form DNA. The resulting strained conformation
is characterized by a ∼50◦ central kink, unwinding of the
DNA, unstacking and twisting of the central two base pairs
of GATATC by intrusion into the minor groove of the Lys
38 side chain from each subunit, and bending of the DNA
making the major groove narrow and deep and the minor
groove wide and shallow. The EcoRV-induced bending of
specific DNA had been confirmed by gel shift assays with
an inactive EcoRV mutant in the presence of Mg2+ (283),
the wild-type enzyme in the presence of Ca2+ (284), and by
scanning force microscopy (285).
The conformation of the EcoRV protein itself also
changes during transition from the non-specific to the spe-
cific complex, a feature we now know to be common among
REases. These changes include reorientation of two sub-
domains allowing EcoRV to encircle the DNA, and or-
dering of three loops that are disordered in the free pro-
tein and the non-specific complex, two of which are in-
volved in recognition by making specific contacts to the
DNA in the major and minor grooves. The principal recog-
nition elements of EcoRV, the R-loops, engage in 12 out
of 18 possible major groove H-bonds with the bases, two
van-der-Waal’s contacts to the methyl group of the outer
thymidines (GATATC) and 12 water-mediated H-bonds to
the DNA backbone (these numbers refer to both subunits
and double-stranded DNA). The other important recogni-
tion element, the Q-loop, forms two H-bonds to the bases
in the minor groove and harbors the catalytically important
residue Asp74 (Figure 6).
It is noteworthy that in the specific EcoRV–DNA com-
plex, no H-bond interactions are present in the major
groove with the two central base pairs (GATATC). Com-
pression of the major groove at this position due to the 50◦
kink limits direct access. Numerous contacts occur between
the protein and the DNA backbone. Not including the R-
and Q-loops, approximately 24 amino acid side chains with
H-bond donor capacity or positive charge are sufficiently
close to phosphate groups to interact favorably. Some of
these contacts are to phosphates outside of the recogni-
tion sequence, and might be responsible for the flanking se-
quence preferences of EcoRV (84,286). The mechanism of
DNA recognition by EcoRV inferred from the crystal struc-
ture has been extensively investigated by site-directed muta-
genesis (77,257,266,286–289). This has shown that substitu-
tion of amino acids involved in base-specific contacts results
in almost inactive variants. Using chemically modified oli-
gos (101,290–295), and oligos with degenerate recognition
sequences (85), the importance of all of the exocyclic groups
in themajor groove of the recognition sequence has been ex-
amined. The inner AT base pairs (GATATC), which do not
have direct contacts with the enzyme, were found to be as
important for the recognition process as the other base pairs
(GATATC). This implies that H-bond, and van der Waals,
interactions with the protein are not the only way sequence
recognition can occur, and that additional factors, such as
conformation-dependent contacts to the DNA backbone
(‘indirect readout’), and steric exclusion, can also be deter-
minants. It is plausible that the propensity of the EcoRV
recognition sequence to adopt an extreme bend between the
central base pairs could exclude other DNA sequences from
productively interacting with this enzyme (259). GC or CG
base pairs are thought unlikely to allow such an extreme de-
formation as AT and TA base pairs. The role of phosphate
contacts for the specific interactions of EcoRV and its tar-
get sequence was systematically analyzed by site-directed-
mutagenesis experiments (286). The complete catalytic cy-
cle of EcoRV has been observed by fast kinetics. EcoRV and
its substrate associate in the presence of Mg2+ in a nearly
diffusion-controlled process, and the binding and bending
steps occur at equivalent rates (296). Positively charged C-
terminal subdomains of EcoRV contribute to DNA bind-
ing, bending and cleavage (297). Binding may occur in two
steps: non-specific binding to the C-terminal subdomain,
followed by opening of the binding cleft and specific bind-
ing (298).
Common features of the EcoRI and EcoRV co-crystal
structures allowed certain generalizations to be made con-
cerning Type II REases, and their interactions with recogni-
tion sequences. These were soon confirmed, and extended,
by the co-crystal structures of PvuII and BamHI, and then
by others that followed.
1. The structures possess 2-fold rotational symmetry, as
suggested byHamilton Smith in hisNobel Lecture (299).
This agreed with experimental results showing that pro-
tein contacts to the two half-sites of the palindromic
recognition sequence were symmetric (65) and that the
two identical subunits of EcoRI cooperate in binding
and cleavage (52,300).
2. The substrate DNA is bound in a high energy confor-
mation with large deviations from a B-form DNA. The
DNA is kinked, though overall straight in EcoRI, and
bent in EcoRV. The DNA is underwound and the base
pairs are partially unstacked. Distortion is part of the
recognition process, and is accompanied by conforma-
tional changes of the protein (296,301–304).
3. The protein–DNA interface is characterized by an intri-
cate set of interactions with both bases and the phos-
phates. Most of the H-bond donor or acceptor atoms
in the major groove of the recognition sequence are in-
volved in H-bonds to the protein, some of them water-
mediated (see also (146)). In addition to interactions
with bases, there are numerous interactions with the
backbone, within and just outside the recognition se-
quence (286,305). Secondary, or buttressing, interac-
tions support primary ones by properly positioning the
amino acids that contact the bases or the backbone.
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4. Primary and secondary interactions form an extensive
network likely established in a highly cooperative man-
ner during the recognition process.
5. The recognition process is redundant in that contacts to
the base pairs are over-determined. Redundancy ensures
that recognition is reliable, and implies that attempts to
alter specificity by changing individual contact amino
acids are unlikely to succeed, as has been amply demon-
strated (306,307).
6. The catalytic site residues of EcoRI and EcoRV com-
prise two acidic amino acids and one lysine, located on
the second and third -strands: D91, E111 andK113 for
EcoRI; D74, D90 and K92 for EcoRV.
There were also notable differences between the EcoRI
and EcoRV structures.
1. EcoRI approaches the DNA, and likely tracks it, from
the major groove. The minor groove is empty with no
protein–DNA contacts. EcoRV approaches the DNA
from the minor groove, and encircles it by wrapping
arms into the major groove. These differences were
later found to be typical for the - (e.g. BamHI, BglII,
Bse634I, BsoBI, Cfr10I, EcoRI, EcoRII, MunI, FokI,
NgoMIV) and - (e.g. BglI, EcoRV, HincII, MspI,
NaeI, PvuII) evolutionary branches of the PD. . .D/ExK
REases.
2. For EcoRI, contacts to the major DNA groove are made
by an extended -sheet and a ‘four barreled’ helix. For
EcoRV, the major groove contacts originate from two
loops.
Structures of non-cognate complexes of REases are avail-
able for only two REases: EcoRV (259) and BamHI (308).
In both cases, the structure of the non-cognate complex is
more open than that of the cognate complex. For BamHI,
it was concluded that the structure of the ‘non-cognate com-
plex provides a snapshot of an enzyme poised for linear diffu-
sion’ (308).
The mechanism of catalysis
One of themost important questions regarding the catalytic
mechanism of a hydrolase is whether hydrolysis involves a
covalent intermediate, as is typical for proteases. This can
be decided by analyzing the stereochemical course of the
reaction. This was done first for EcoRI (112), and later for
EcoRV (116). Both enzymes were found to cleave the phos-
phodiester bond with inversion of stereoconfiguration at
the phosphorus, which argues against the formation of a
covalent enzyme–DNA intermediate (Figure 7). Bfi is the
only REase known to catalyze a transesterification reaction
on DNA with retention of configuration at the phospho-
rus, which is indicative of a two-step mechanism. BfiI has a
rare phospholipase-D catalytic site and has been shown to
cleave the twoDNA strands sequentially in a highly unusual
manner that involves covalent enzyme–DNA intermediates
(309).
Crystallographic analyses of the specific complexes of
EcoRI (258) and EcoRV (259,281), in combination with
mutagenesis, identified the catalytic sites of these enzymes
Figure 7. A general mechanism for DNA cleavage by EcoRI and EcoRV.
An activated water molecule attacks the phosphorous in-line with the
phosphodiester bond to be cleaved by an SN2 reaction, which proceeds
with inversion of configuration. X, Y and Z are a general base, a Lewis
acid and a general acid, respectively.
(265). They were found to be closely similar in struc-
ture and behavior (Figure 8). Comparable catalytic sites
were later found in other REases when their crystal struc-
tures were determined. These sites contained the signature
‘PD. . .D/EXK’ motif, a motif that occurs in many varia-
tions and can be difficult to identify in the absence of struc-
tural information because the two components, PD and
D/EXK, are not invariant, and can be separated (‘. . . ’) by
anywhere from 4 (BcnI) to 51 (SgrAI) amino acids. Com-
pounding matters, in some enzymes, the D/E or K residues,
are recruited from other parts of the protein (e.g. EcoRII
(310); BspD6I (311)). The importance of the acidic and ba-
sic amino acid residues for cleavage activity has been con-
firmed many times by site-directed mutagenesis (77,254–
255,266,274,312), although their role is not fully estab-
lished, and the precise mechanism of catalysis is still sub-
ject to interpretation. When crystallized with metal ions
(Mg2+, Mn2+, Ca2+ or Na+), one ion is consistently found
at the same position in the catalytic site, coordinated to one
non-bridging oxygen atom (always proS) of the target phos-
phate, and up to five other oxygen atoms from the side chain
carboxylates of the acidic residues, D and D/E; the main-
chain carboxyl of residueX; andwatermolecules. Themetal
ion is thought to stabilize the transition state by neutral-
izing the build-up of negative charge on the phosphorus.
Often a second ion is present, too, close to the 3′-leaving
group, but its position varies somewhat. The lysine residue
(K), which in some REases is replaced by E (e.g. BamHI
(261)), Q (e.g. BglII (313) and NotI (25)), or even N (e.g.
MspI (269)) might stabilize the transition state. Some also
consider this to be the general base which de-protonates a
water molecule to create the attacking hydroxide ion, al-
though others argue that this is unlikely.
In what is termed ‘substrate-assisted catalysis’ (314), the
phosphate group 3′ to the hydrolyzed phosphate is another
candidate for the general base in EcoRI and EcoRV (113),
and also other REases (e.g. EcoO109I (315)). In EcoRV,
two other carboxylates––not those of the PD. . .D/EXK
motif––were discussed as being responsible for water acti-
vation (316). Alternatively, the attacking water could be ac-
tivated by a water molecule from the hydration sphere of
the Mg2+ ion at the catalytic center, or be one of a hydra-
 at Bibliothekssystem
 der U
niversitaet G
iessen on February 10, 2015
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
7502 Nucleic Acids Research, 2014, Vol. 42, No. 12
Figure 8. The active site (PD. . .D/ExK) of EcoRI and EcoRV.
Figure 9. An example of a REase catalytic site (MvaI, pdb: 2OAA). The
nucleophilic water is oriented with tetrahedral geometry to ‘attack’ the
phosphorus: one H-bond is to K87 and one H-bond to the 3′-phosphate
oxygen, both of which might act as the general base. One lone pair orbital
of the attacking water is to the metal ion, and one lone pair orbital to the
phosphorus atom.
tion sphere water molecules itself (e.g. MvaI, Figure 9 and
BcnI (131,132)). Rosenberg et al., who have been able to fol-
low the cleavage reaction by EcoRI in the presence of Mn2+
in crystallo, suggested that the attacking nucleophile is an-
other water molecule close to the water molecule bound
to the Mn2+, one per subunit (301). All of these candi-
dates for the general base have unfavorable pKa values, but
those of ionizing groups at catalytic centers often deviate
by several units from their values in free solution. There is
also uncertainty about the extent to which a general base is
needed. If the mechanism is not always associative (involv-
ing a penta-covalent transition state), but instead is some-
times dissociative (involving a trigonal transition state; Fig-
Figure 10. Alternative mechanisms of phosphoryl transfer reactions: asso-
ciative (top) and dissociative (bottom). The mechanisms differ in the order
of bond formation and breakage, and in the nature of the transition state
(317).
ure 10), then water activation becomes less important, and
transition state stabilization becomes very important (317).
It is also unclear which entity is responsible for proto-
nation of the leaving group. A likely candidate is a water
molecule from the hydration sphere of the metal ion cofac-
tor, but the leaving group could also be stabilized by associ-
ation with aMg2+ ion. Because of the superficial similarities
of the active sites of PD. . .D/EXK enzymes, it is tempting
to assume that they all operate in the same way, but the re-
action mechanisms of different REases could be similar in
some respects, but differ in others. One difference relates to
the number of Mg2+ ions. As noted by Warshel et al. (318):
‘The detailed mechanism of DNA hydrolysis by enzymes is of
significant current interest. One of the most important ques-
tions in this respect is the catalytic role of metal ions such as
Mg2+. While it is clear that divalent ions play a major role
in DNA hydrolysis, it is uncertain what function such cations
have in hydrolysis and why two are needed in some cases and
only one in others’. The question of how many Mg2+ ions
are involved in catalysis is still unanswered because differ-
ent numbers of divalent metal ions (often Ca2+ instead of
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Figure 11. Comparison of the active sites of two structurally very similar
restriction enzymes BglII (PDB 1D21, with one Na+ ion in the active cen-
ter, which can be replaced by a Ca2+ ion by soaking) and BamHI (PDB
2BAM, with two Ca2+ ions in the active center) (313).
Mg2+, to avoid cleavage) are found in the co-crystal struc-
tures of different REases with their substrates or products
(319). In EcoRI and in BglII (313), only a single metal ion is
found at the active site; in EcoRV and BamHI (320), there
are two (Figure 11).
Different numbers of metal ions are also found in dif-
ferent crystal forms of the same REase–DNA complex. In
some co-crystal structures, there are two metal ions in one
subunit and none in the other (281,320), or two metal ions
in three different locations (321). For EcoRI it was shown
that a single Mn2+ ion participates in the cleavage reac-
tion in crystallo (301). The question arises, then, whether
the number of metal ions seen in co-crystal complexes–
–particularly when these are Ca2+––accurately reflect the
number of Mg2+ ions needed for catalysis. Given these am-
biguities one cannot decide how many Mg2+ ions are re-
quired for DNA cleavage by REases. And also, whether
these enzymes all follow exactly the same mechanism for
phosphodiester bond hydrolysis (8).
In a recent systematic study of several REases, among
them EcoRI and BamHI, which were assumed to follow
a mechanism involving exclusively one Mg2+ ion or exclu-
sively twoMg2+ ions, all were found to exhibit similarMg2+
(orMn2+) concentration dependence, and similar kinetics in
response to the presence of Ca2+ in addition to Mg2+. This
study concluded that Type II REases generally have two
Me2+ binding sites per active center: a high-affinity site (site
A), where a Mg2+ or Mn2+ ion is required for cleavage, and
a low-affinity site (site B) which is inhibitory when occupied
by Mg2+ or Mn2+, but stimulatory when occupied by Ca2+
at low concentration. Thus, oneMg2+ orMn2+ is critical for
REase-activation, and binding of a secondMe2+ modulates
this activity. These conclusions are supported by molecu-
lar dynamics simulations, and they are consistent with the
structural observations of both one and twoMe2+ ion bind-
ing in these enzymes (322). The study also suggested that the
essential Mg2+ ion might move from site A to site B dur-
ing catalysis. In a very recent paper with the suggestive ti-
tle ‘One is enough: insights into the two-metal ion nuclease
mechanism from global analysis and computational stud-
ies’ results of experiments were published that collectively
support a mechanism in which only one metal ion is nec-
essary for nucleic acid hydrolysis by REases (323). We con-
clude from these studies, then, that there is no general con-
sensus on the number of Mg2+ ions involved in catalysis.
Variations on a theme: subtypes of Type II restriction en-
zymes
Early investigations of Type II REases focused on EcoRI
and EcoRV, but it became clear as more such enzymes were
discovered that there were marked differences among them.
They were not all cut from the same cloth, so to speak, not
even near. Even among enzymes with comparable activi-
ties, such as EcoRI (G|AATTC) and BamHI (G|GATCC),
or XmaI (C|CCGGG) and SmaI (CCC|GGG), little simi-
larity was found at the amino acid sequence level. This di-
versity came as a surprise to many investigators, and there
is still no general agreement what it means, evolutionar-
ily. Given the metabolic adroitness of prokaryotes, their
infinite niches, rapid propagation and endless life-span, it
seems likely that every evolutionary scenario possible has
had a hand in shaping what we see today, possibly indepen-
dently many times, in many places. Among Type II REases,
compelling examples of convergent evolution abound (e.g.
HaeIII, NgoPII and BsuRI (171)), as too do compelling
examples of divergent evolution (e.g. Bsu36I, BplI, Bpu10I
and BbvCI (324)), neutral drift (e.g. EcoRI and RsrI) and
perhaps mosaicism (EcoRI, MunI and MluCI). Examples
of gene fusion, separation and exchange are common. All
this attests to the genetic resourcefulness of prokaryotes,
and to the viral assaults they endure.
There are several ways to bring order to this variety.
The conventional way of grouping by genotype (i.e. phy-
logenetic proximity) is impractical because many Type II
REases show no more similarity to one another than do
proteins chosen at random. Alternately, REases can be
grouped by phenotype based on their behavior and cleav-
age properties. This is the approach used in the current
classification scheme proposed by Roberts and adopted by
consensus a decade ago (14). Accumulating information,
and improved understanding in the interim, has revealed
weaknesses in this scheme, and it will likely be revised in
the not-too-distant future. Other ways of classifying Type
II REases include grouping enzymes whose structures or
subunit/domain organizations are similar (268), or whose
catalytic sites are of similar kinds. A discussion of some of
these groupings follows.
Grouping enzymes by behavior. In the survey and nomen-
clature of Type II REases by Roberts et al. (14), 11 sub-
types were defined each with a particular, but not necessar-
ily unique, property: A, B, C, E, F, G, H, M, P, S and T.
EcoRI, EcoRV and most of the familiar laboratory cloning
enzymes belong to the so-called ‘IIP’ subtype because they
recognize palindromic (symmetric) DNA sequences. In this
classification scheme, subtypes are not mutually exclusive,
and enzymes can belong to several subtypes at once. FokI,
for example, is perhaps the best-known member of the ‘IIS’
subtype (shifted cleavage), but it also belongs to the ‘IIA’
subtype because its recognition sequence is asymmetric.
And BcgI, an extreme example, belongs to six, and ar-
guably more, subtypes (325). Supplementary Table S3 gives
an overview of the occurrence of the subtypes among char-
acterized REases, as summarized in REBASE. Figure 12
shows schematically the subunit composition and cleavage
processes of selected subtypes.
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Figure 12. The subunit composition and cleavage mechanism of selected subtypes of Type II REases. Type IIP enzymes act mainly as homodimers (top),
and cleave both DNA strands at once. Some act as dimers of dimers (homotetramers) instead, and do the same. Still others act as monomers (bottom)
and cleave the DNA strands separately, one after the other. Bright triangles represent catalytic sites. Type IIS enzymes generally bind as monomers, but
cleave as ‘transient’ homodimers. Type IIB enzymes cleave on both sides of their bipartite recognition sequences. Their subunit/domain stoichiometry and
polypeptide chain continuity varies. Three examples of primary forms are shown: BcgI, AloI and HaeIV. These forms assemble in higher-order oligomers
for cleavage. Type IIB enzymes display bilateral symmetry with respect to their methylation and cleavage positions. It is not clear whether they cleave to
the left or to the right of the half-sequence bound. Type IIG enzymes (e.g. BcgI) might cleave upstream (left) of their bound recognition half-site. All other
Type IIG enzymes (e.g. MmeI) cleave downstream from the site, often with the same geometry. These proteins have very similar amino acid sequences,
however, suggesting that somehow the reactions are the same. Type IIT enzymes cleave within or close to asymmetric sequences. Composition varies; they
have two different catalytic sites: top-strand specific and bottom-strand specific. In some, both subunits/domains interact with the recognition sequence
(left cartoons). In others, only the larger subunit/domain recognizes the DNA.
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Type IIA. Type IIA enzymes, for example SapI
(GCTCTTC 1/4), recognize asymmetric sequences
and cleave within, or a defined distance away from, the
sequence. Many are accompanied by one or two DNA
methyltransferases (MTases) that each modify one strand
of the recognition sequence. Others are combination
restriction and modification (RM) enzymes, some of which
have separate accompanying MTases, while others do not.
Asymmetric recognition sequences occur more frequently
in DNA than do symmetric sequences and so, a priori,
one might expect Type IIA REases to be more abundant
than Type IIP. This is not the case, however. Type IIP
enzymes recognize their sequences overwhelmingly as
homodimers––this being the most efficient use of genetic
resources––and so they are more common than they would
otherwise be.
The fundamental challenge for REases of all types is that
the reaction they catalyze is polarized and strands of DNA
have opposite polarities. Only one reaction trajectory pro-
duces 5-phosphate, 3-hydroxyl ends. To generate these on
both strands requires either that the catalytic site works in
both directions, or that it adopts the opposite orientation
for each strand. If it can work in both directions then, in
principle, the same site could cleave both strands, one af-
ter the other, without switching orientations. If it can work
in only one direction, however, it must swivel 180◦ between
strands. And if it cannot swivel, then either the entire en-
zyme must detach, rotate and reattach––available only to
REases with symmetric specificities––or two catalytic sites
in opposite orientations must be present in the enzyme to
begin with. The symmetric catalytic site of BfiI (ACTGGG
5/4), formed at the subunit interface of a homodimer, was
for a time thought to act bi-directionally (326), but now
it is believed to swivel, instead (327). No other REase cat-
alytic site is known to swivel, and none are known to act bi-
directionally, although examples might well be found even-
tually.
Type IIP enzymes take advantage of dimerization for
DNA cleavage as well as for recognition by using two copies
of the same catalytic site to juxtapose the twoDNA strands.
Most Type IIA enzymes are thought to dimerize too, in or-
der to cleave, but only briefly. The recognition and cleavage
components of Type IIA enzymes are usually segregated
into different domains. The recognition domain binds to
DNA individually and asymmetrically, but the cleavage do-
main is thought to dimerize with an identical domain from
another molecule for cleavage. Evidence for this ‘transient
dimerization’ (328,329) comes mainly from kinetic studies
which indicate that cleavage is cooperative. With these en-
zymes, cleavage rates often increase disproportionately with
increasing enzyme concentration, and are usually higher on
substrates with multiple recognition sequences than on sub-
strates with single recognition sequences. Not all Type IIA
REases dimerize transiently, however. Some use two dif-
ferent catalytic sites instead, from different subunits (e.g.
BbvCI) or from different domains within the same protein
chain (e.g. Mva1269I). These enzymes tend to cleave within
the recognition sequence or very close to it, at positions in-
accessible to separate dimeric catalytic domains.
Type IIB. Type IIB enzymes (reviewed by Marshall and
Halford (325)), for example BcgI (10/12 CGA N6 TGC
12/10), cleave DNA on both sides of their recognition se-
quence, releasing a small (e.g. 34 bp) fragment that contains
the recognition sequence. They are large, complex, RM en-
zymes that methylate DNA in addition to cleaving it. They
function alone, without accompanying MTases. Type IIB
recognition sequences are bipartite, comprising two specific
‘half-sites’ separated by a short non-specific gap. The en-
zymes are related to, and share many features in common
with, Type I REases (see Loenen et al. for a comparison
(1)). Their catalytic site for cleavage belongs to the PD-
D/EXK superfamily (330) and forms the N-terminal do-
main of the RMprotein. Cleavage produces 3′-overhangs of
two to five bases, suggesting that the catalytic sites juxtapose
across the minor, rather than the major, DNA groove. Their
catalytic site for methylation belongs to the gamma-class
(NPPF/Y/W) family; it lies distal to the cleavage domain
in the RM protein and methylates adenine residues. Methy-
lation converts one A in the top strand of the first (5′) half-
site to N6-methyladenine (m6A) and one A in the bottom
strand of the second (3′) half-site. AdoMet is required for
methylation and also, in some enzymes, for cleavage (331).
In principle, when Type IIB enzymes encounter a recog-
nition sequence, they have three options: they can ignore
the sequence (neutral mode); they can cleave it (restriction
mode); or, they can methylate it (modification mode). To
act appropriately according to circumstances requires some
sophistication (332,333). How these alternative modes are
implemented is not clear, but the signal is likely to be the
methylation states of the recognition half-sites. If both half-
sites are methylated ( = fully modified host DNA), the se-
quence should be ignored. If only one half-site is methy-
lated ( = newly replicated host DNA), the other must be re-
methylated. And if neither half-site is methylated (= poten-
tially foreignDNA), the enzymemust refrain frommethyla-
tion, and either cleave the sequence immediately or wait un-
til its significance becomes clearer. The simplest, restriction-
only, Type IIP enzymes such as EcoRI and BamHI cleave
immediately they encounter an unmethylated recognition
sequence, but Type IIB enzymes, and many others, in ef-
fect assess the situation first. If multiple sequences are un-
methylated ( = verified foreign DNA), the DNA is cleaved.
But if only one is unmethylated ( = inadvertently unmod-
ified host DNA), cleavage is suppressed, and the sequence
is eventually re-methylated. All of these steps involve sens-
ing, subunit intercommunication and catalytic adaptation
to suit.
BcgI, CspCI and BsaXI possess separate sequence-
specificity (S) subunits that, like Type I S-subunits, comprise
two opposed sequence-recognition domains, one for bind-
ing each half-site. The biochemistry of BcgI, and of other
Type IIB enzymes, has been studied in depth by Stephen
Halford’s group at Bristol University. BcgI has the subunit
stoichiometry 2RM:1S, in which one RM catalytic subunit
associates with one sequence-recognition domain (334). It
exists as a hetero-hexamer––a dimer of trimers (2× [2RM
+ 1S])––in solution and also when bound to DNA (335).
In restriction mode, BcgI is active only when bound to two
recognition sequences, whereupon cleavage of all four dou-
ble strands occurs at once (333,336). This involves hydrol-
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ysis of eight phosphodiester bonds and requires four ad-
ditional catalytic sites that are thought to be contributed
by neighboring enzyme molecules, or by surplus individual
RM subunits. In modification mode, BcgI binds single se-
quences also as a hexamer. It methylates hemimethylated
sequences rapidly, but unmethylated sequences are methy-
lated 100-fold less efficiently. BcgI is thus far more of a
‘maintenance’ MTase than a ‘de novo’MTase, and is in fact
the most extreme prokaryotic example known (332). These
cleavage and methylation properties of BcgI are consistent
with the ‘wait and see’ mechanism discussed above.
Other Type IIB REases, including AloI, PpiI (337) and
CjeI, are single-chain proteins, in which the specificity por-
tion, again comprising two sequence-recognition domains,
forms the C-terminus of a composite, single-chain protein
of composition RMS. In these enzymes, subunit fusion re-
sults in an imbalance in the number of catalytic and speci-
ficity components. It is not entirely clear how these proteins
function, with only one catalytic domain to share between
two recognition half-sites. Recent study of the single-chain
enzyme, TstI, indicates that it acts as a homotetramer bound
to two bipartite recognition sequences rather than four, and
behaves in a different fashion to BcgI in both cleavage and
methylation (338). As with Type I RM enzymes, the indi-
vidual sequence-recognition domains of Type IIB enzymes
function independently, and can be ‘swapped’ for one an-
other to generate enzymes with new combinations of recog-
nition sequence specificities (337). Most Type IIB enzymes
are inactive as endonucleases when bound to single recog-
nition sites (325,331), and active when bound to two sites
preferably in cis on the same DNA molecule, or in trans on
concatenates. To cleave multiple DNA duplexes at once re-
quires these proteins to assemble into large oligomers with
molecular masses in excess of 500 kDa, making them the
largest REases known (333). None of the Type IIB enzymes
have been crystallized. Much remains to be learned about
them, and it is clear that they are not straightforward.
Type IIC. Type IIC enzymes (combined) have endonucle-
ase and methyltransferase activities in the same protein.
Themajority comprise anN-terminal PD-D/EXKendonu-
clease domain followed by a gamma-class (NPPY/F/W)
methylation domain, and they include all the known Type
IIB REases mentioned in the previous section. At least one
Type IIC enzyme is known that differs: BtgZI (GCGATG
10/14). This REase comprises instead anN-terminal alpha-
class MTase, and a C-terminal variant of the PD-D/EXK
domain in which glutamine (Q) replaces glutamate (E).
Cleavage by BtgZI creates a 4-base, 5′-overhang instead
of the usual 3′-overhang. Some Type IIC REases function
without a separate MTase (e.g. MmeI). Others, such as
Eco57I (339,340), are accompanied by one MTase, and yet
others, such as BpuSI, (341) by twoMTases. Most Type IIC
REases bind to their target sequences as monomers. Some
recognize sequences that are continuous and asymmetric,
and they cleave on only one side of the sequence approxi-
mately one turn of the helix away (e.g. Tth111II; CAARCA
11/9), one and one-half turns away (e.g. Eco57I: CTGAAG
16/14), or two turns away (e.g. MmeI (TCCRAC 20/18)).
Others, including the single-chain Type IIB enzymes such
as AloI (7/12 GAAC N6 TCC 12/7), have two different
sequence-specificity domains, and so their recognition se-
quences are bipartite and asymmetric, and they cleave on
both sides (342). A few, such as HaeIV (7/13 GAYN5RTC
14/9), bind as homodimers using two copies of the same
specificity domain (343). Their recognition sequences are
also bipartite, but symmetric, and they also cleave on both
sides. HaeIV makes the first strand cleavage randomly on
either side of the recognition sequence; the second strand
cleavage occurs more slowly (343).
Among Type IIC enzymes, the crystal structure of BpuSI
(GGGAC 10/14) has been solved, but without DNA (344).
The structures ofMmeI andNmeAIII have also been solved
recently (345), the former with DNA, and are awaiting
publication. Type IIC RM proteins possess only one en-
donuclease catalytic site, yet cleave both DNA strands.
Cleavage is presumed to involve ‘transient dimerization’ be-
tween the catalytic domains of neighboring molecules, as
has been proposed for FokI (328,329). For many Type IIC
enzymes, cleavage efficiency increases when the substrate
DNA contains multiple recognition sites, or when oligos
containing recognition sequences are added. Multiple sites
are thought to raise the local enzyme concentration and
thereby enhance transient dimerization, and specific bind-
ing is thought to render the catalytic domain competent to
dimerize. Type IIC enzymes cleave away from their recog-
nition sites, and the distance can vary by ±1 or 2 bp. The
‘reach’ between the recognition sequence and the cleavage
sites is thought to depend upon physical distance rather
than the number of intervening base pairs, and this can vary
according to DNA topology, ionic conditions and base pair
sequence. For enzymes that cut on both sides of bipartite
recognition sequences, when the reach is measured from the
adenine that becomes modified in each half-site rather than
the boundaries of the recognition sequence, it is typically the
same on the left as on the right, because the same protein
catalyzes both reactions on both sides.
Type IIE. The simplest Type II REases such as EcoRI and
BamHI cleave DNA efficiently regardless of the number of
recognition sites present in the substrate molecule. EcoRII
(|CCWGG; (47,50)), discovered shortly after EcoRI, be-
haves differently and requires multiple sites for efficient
cleavage. EcoRII acts as a homodimer and binds to two
(346) or three (347,348) copies of its pseudo-palindromic
recognition sequence at once. Like other homodimers, one
sequence is bound concertedly by the two subunits, in
the normal DNA-recognition groove between them (349).
This sequence becomes cleaved, and it is bound by the
C-terminal domains of the EcoRII subunits, which con-
tain the catalytic sites. (Surprisingly, it was found that the
central A and T (W) bases of the CCWGG sequence are
flipped out from the helix by EcoRII, and by similar en-
zymes such as PspGI (|CCWGG) and Ecl18kI/SsoII (|CC-
NGG), compressing the recognition sequence in effect to
just CC-GG (90).) The other sequences are bound in a dif-
ferent way by EcoRII, without cleavage, by the individ-
ual N-terminal domains that act as allosteric activator(s)
or effector(s) (349,350). Type IIE REases are Type IIP en-
zymes with allosteric effector domains that stimulate catal-
ysis when bound to additional recognition sequences (re-
viewed by Mucke et al. (351)). NaeI (GCC|CCG), another
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example of a Type IIE REase (229,352), has an intriguing
functional connection to DNA topoisomerases (353,354),
and, like EcoRII, it induces looping in bound DNA (355),
and it can be stimulated by oligos containing its recogni-
tion sequence to cleave otherwise refractory sites (356). The
properties of loop formation, and stimulation by the ad-
dition of specific oligos, are typical of these enzymes. The
biological function of allosteric activation is unclear, but
it might be to spare the cell’s own DNA from cleavage at
inadvertently unmodified sites during periods when DNA
methylation fails to keep up with DNA synthesis. The same
might also pertain to the Type IIF enzymes described below.
Type IIF. Type IIF enzymes [reviewed by Siksnys et al.
(357)] bind two recognition sequences and cleave coordi-
nately, hydrolyzing all four DNA strands at once. Type IIE
REases also act by binding two (or more) sequences, but
they differ from Type IIF enzymes in that when they do,
only one of the sequences is cleaved because their bind-
ing sites differ: one is solely catalytic, the other(s) solely
allosteric. Type IIF REases, in contrast, act as homote-
tramers; their binding sites are identical and catalytic, but
they have allosteric, or ‘cooperative’, properties, too. Some
of these REases, such as the Type IIB TstI mentioned
above and the Type IIS BspMI (358), recognize asym-
metric sequences with structural organizations that remain
uncertain. Others, such as SfiI (GGCCNNNN|NGGCC)
(359), the related REases Cfr10I/Bse634I (R|CCGGY)
and NgoMIV (G|CCGGC) (360–362), and possibly PluTI
(GGCGC|C) (363), recognize symmetric sequences as pairs
of ‘back-to-back’ homodimers. The binding site of each ho-
modimer is catalytic, like those of ordinary homodimers,
but unable to cleave unless the other binding site is also oc-
cupied. Both binding sites must be occupied, then, for ei-
ther to be active and when they are, both sequences cleave
at once (360364). For reasons of stability, binding two se-
quences in cis is preferred to binding in trans, and results
in looping out of the intervening DNA (365). The way in
which DNA binding is signaled between the catalytic sites
is unclear, but likely involves conformational changes that
propagate across the tetramer interface (362). In Bse634I,
mutation at this interface results in homodimers that bind
and cleave single recognition sequences efficiently, indicat-
ing that tetramerization is inhibitory (362). A mutation at
the tetramer interface of SfiI also relieves inhibition by al-
lowing the enzyme to bind to a single sequence and cleave
it efficiently while remaining a tetramer (128).
SgrAI (CR|CCGGYG) belongs to the same enzyme fam-
ily as Cfr10I/Bse634I and NgoMIV. It is more active on
substrates with two recognition sequences than one, and
cleaves both sequences concertedly (366). SgrAI also as-
sembles into homotetramers, but then goes further and
forms ‘run-on’ oligomers comprising helical filaments of
one DNA-bound homodimer after another. Adjacent ho-
modimers are offset ∼90◦, rather than back-to-back, and
four homodimers together form almost one turn of a left-
handed spiral, which can comprise up to 18 homodimers
and possibly more (367). In this oligomeric form, SgrAI is
highly active on both its canonical sequence and on a ‘star’
sequence, CR|CCGGYN (N = any base). The allosteric ef-
fect is thought to stem from interactions between the mi-
nor groove of the DNA flanking the recognition sequence
and protein loops to the side of the binding site. Cleavage
of star sequences is less efficient (4%) than cleavage of the
canonical sequence (368), but it is much higher than oc-
curs with most other REases. It implies that the SgrAI ho-
modimer is somewhat asymmetric, such that one subunit
consistently recognizes the outer base pair of the recog-
nition sequence, while the other subunit sometimes does
not. The homodimer undergoes significant conformational
adjustments when it assembles into oligomers (367), and
these changes might introduce asymmetry with respect to
sequence recognition.
RelatedREases can act as either Type IIE or IIF enzymes.
EcoRII (|CCWGG; Type IIE) and Ecl18kI/SsoII (|CC-
NGG; Type IIF), for example, interact with their recog-
nition sequences as homodimers, and use similar base-
recognition, base-flipping and cleavage mechanisms. The
two enzymes are structurally similar except for the N-
terminal allosteric effector domain of EcoRII, which is not
present on Ecl18kI/SsoII. Nevertheless Ecl18kI/SsoII, like
EcoRII, is more active on substrates with multiple recogni-
tion sites than on substrates with single sites, suggesting that
binding to two sites is required for DNA cleavage. Instead
of possessing a dedicated effector domain like EcoRII, how-
ever, Ecl18kI/SsoII assembles into a ‘transient’ tetramer
to accomplish cleavage (369). Evolutionarily diverged ver-
sions of the same enzyme can also act in different ways.
Cfr42I and Eco29kI, for example, recognize and cleave the
same DNA sequence, CCGC|GG, and have similar GIY-
YIG catalytic sites (242370). Cfr42I is a tetramer in solu-
tion, binds to two recognition sequences, and cleaves both
sequences at once (21). Eco29kI, in contrast, purifies as a
monomer in solution (371), but binds to its recognition se-
quence as a homodimer, and cleaves one recognition se-
quence at a time (372); Eco29kI also crystallizes with DNA
as a homodimer (239); Cfr42I has not been crystallized.
Type IIG. Type IIG REases are stimulated by, or abso-
lutely require, AdoMet. Most of the Type IIB and Type
IIC enzymes are of this kind, and the group as a whole
is referred to loosely as ‘Type IIG’. These are combined
RM enzymes, with a DNA-cleavage domain and a gamma-
class DNA-methylation domain in a single protein chain.
Both R andM catalytic activities are harnessed to the same
sequence-specificity module (S), which can occur as a sep-
arate subunit or as the C-terminus of the RM protein. S-
modules can recognize single (continuous) DNA sequences,
or bipartite (discontinuous) sequences, either of which can
be symmetric or asymmetric. Type IIG enzymes occur in
a variety of oligomeric forms, with or without separate,
accompanying MTases. A summary of Type IIG REase
organizations, and of their relationship to Type I REases
and certain Type II MTases, is given in Loenen et al. (1).
AdoMet is the donor of the methyl group, and so it is essen-
tial for the methylation reaction. Since it also either stimu-
lates, or is absolutely required for, the cleavage reaction, it
likely acts as an allosteric activator, too. The advantage of
AdoMet dependency againmight be self-preservation, since
it reduces the likelihood that the cell’s own DNA will be
cleaved at times ofAdoMet shortage and consequent under-
modification. Since Type IIG enzymes methylate as well as
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cleave DNA, in vitro digestions often fail to go to comple-
tion. A proportion of sequences become modified during
incubation, and thereafter are resistant to cleavage (338).
The crystal structure of BpuSI (GGGAC10/14) has been
solved without bound DNA (344). The enzyme comprises
an N-terminal endonuclease domain, a central gamma-
class methyltransferase domain, and a C-terminal speci-
ficity domain. Structural comparisons and modeling show
that in order to bind DNA specifically, the C-terminal do-
main of BpuSI must rotate with respect to the R andM do-
mains, and reorganize. Large rearrangements often accom-
pany DNA binding by REases, as can be seen by compar-
ing the crystal structures of unbound and specifically bound
forms of, for example, MvaI (pdb:2OA9 and 2OAA (131)),
EcoO109I (pdb:1WTD and 1WTE (315)) andHinP1I (pdb:
1YNM and 2FKC (130373)).
If the DNA sequence recognized by Type IIG enzymes
changes––by mutations in the S-module (374), for exam-
ple, or by domain exchange (337)––it does so for both re-
striction and modification activities in the same way at the
same time. This functional synchrony has allowed the speci-
ficities of certain Type IIG enzymes, such as those of the
MmeI-family, to diverge widely in the course of evolution.
Numerous MmeI-family enzymes have been characterized,
each similarly organized and similar in aa sequence and
hence structure, but specific for a different 6–8 bp recog-
nition sequence ((375) and Supplementary Table S1, group
E). The C-alpha backbone of the recognition domain of
these proteins has evolved a conformation that allows dif-
ferent pairs of amino acids to specify alternative base pairs
in the sequence recognized. Thus E806. . .R808 (Glu. . .Arg)
in MmeI (TCCRAC 20/18) specifies C at the last posi-
tion of the recognition sequence, whereas K806. . .D808
(Lys. . .Asp) specifies G, instead (i.e. TCCRAG) (374).
Other pairs of amino acids within the specificity domain
determine other base pairs in the recognition sequences.
This is unusual behavior for restriction enzymes, which as
a whole have evolved in the other direction, toward recog-
nition sequence immutability, instead (313).
Because the sequences recognized by MmeI-family en-
zymes are generally asymmetric, only one DNA strand
becomes methylated––always the invariant adenine in the
‘top’ strand: TCCRAG, in the case of MmeI (376). When
such hemimethylated sequences replicate, one daughter du-
plex retains the hemimethylation, but the other becomes
completely unmethylated. How unmethylated daughter se-
quences are distinguished from foreign DNA is unclear, but
it seems likely that pairs of sequences in opposite orienta-
tions, and perhaps several pairs, are monitored before the
enzyme commits to either cleavage or re-methylation.
MmeI-family enzymes cleave substrates with multiple
sites more efficiently than substrates with single sites, and
cleavage is stimulated by the addition of oligos that con-
tain a recognition site. The enzymes purify as monomers,
but there are strong indications that they cleave as homod-
imers (or higher-order oligomers) formed between enzyme
molecules bound to adjacent, opposed recognition sites.
When modeled, the structures of these complexes closely
resemble Type I REases, with the difference that Type IIG
cleavage domains cut DNA at fixed positions close to their
recognition site(s) whereas Type I R-subunits cleave at vari-
able distances, far away.Attempts to harmonize the cleavage
behavior ofMmeI (TCCRAC20/18) and Type IIB enzymes
such as BcgI (10/12 CGA N6 TGC 12/10) that are organi-
zationally similar suggest that when these proteins bind to
their recognition site(s), their endonuclease domains might
cleave, not the DNA at the site to which they are bound, but
rather the DNA at the other site, instead. Unless we mis-
read the situation, enzymes of this kind perform some in-
teresting gymnastics in the course of their cleavage reactions
(333,338). The catalytic complexes of Type IIG enzymes are
likely to be large and difficult to solve by crystallography.
Alternative approaches such as single particle cryo-electron
microscopy and reconstruction (367,377,378), or molecular
modeling (379), might prove fruitful in the interim.
Most prokaryotes encode no more than one or two Type
IIG REases, along with a variety of Type I, Type IIP, Type
IIS and, less frequently, Type III enzymes. Extreme differ-
ences can be found, however. Helicobacter pylori isolates
tend to have large numbers of Type IIP and IIS systems––up
to 20––and four to six Type IIG systems. Borrelia burgdor-
feri isolates, in contrast, can have up to 20 Type IIG systems,
to the complete exclusion of all other types. We know little
about the selective advantages and disadvantages that un-
derlie these variations.
Type IIH. When the AhdI R–M system was analyzed,
it was found to comprise a Type IIP-like REase (GAC-
NNN|NNGTC) and an unusual accompanying MTase
(GAC N5 GTC; ‘A’ = position of m6A-methylation). The
M.AhdI MTase consisted of a catalytic subunit for methy-
lation (M) and a separate specificity subunit (S) for DNA
sequence recognition, and it acted as a 2M+2S tetramer, an
organization suggestive of ancestral Type I MTases (380).
AhdI was colloquially referred to as a ‘Type 112 ’ R–M
system because it was a ‘missing-link’ in the evolutionary
chain, part Type I and part Type II. ‘Type 112 ’ was infor-
mal, and so Type IIH (hybrid) was adopted instead. We
now know that in addition to forming the core of all Type
I and most Type IIG REases, the gamma-class adenine-
MTases (the NPPY/F/W group), of which M.AhdI is one,
are widespread and adaptable, and accompany many Type
II REases, both those recognizing continuous sequences
(e.g. M.TaqI: TCGA; HincII: GTYRAC) and those rec-
ognizing bipartite sequences (e.g. M.DrdI: GAC N6 GTC;
M.XcmI: CCA N9 TGG). The Type IIH distinction seems
less important, now, as also do several of the other Type II
sub-classifications, and it is rarely used.
Type IIM. Type IIM enzymes require methylated recog-
nition sequences. The best-known example is DpnI
(Gm6A|TC), discovered by Lacks and Greenberg (381).
DpnI acts as a monomer and cleaves its recognition
sequence one strand at a time, as do several other Type II
REases with short recognition sequence, such as HinP1I
(373), and BcnI (132). DpnI consists of an N-terminal
catalytic PD-D/EXK domain, and a C-terminal winged
helix (wH) allosteric activator domain. Both domains bind
DNA in a sequence- and methylation-dependent manner.
DpnI has been crystallized with DNA bound at the C-
terminal effector domain, but not at the catalytic domain
(24). DpnII, an allelic alternative to DpnI in vivo, cleaves
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the same GATC sequence, but only if it is unmethylated
(382). The complementary specificities of DpnI and DpnII
proved to be very useful for site-directed mutagenesis
experiments. It remains unclear what structural features of
DpnI account for its absolute dependence on methylated
adenines within its recognition sequence. Methyl groups
can increase the affinity between a protein and a DNA
sequence through hydrophobic interactions, but this will
hardly produce the all-or-nothing behavior seen among
the methylation-dependent REases. It is possible, instead,
that the methyl groups induce a structural change by, for
example, altering the side-chain conformations of long-
chain amino acids such as arginine and lysine, switching
them from conformations that interfere with and prevent
binding, to conformations that are compatible with and
permit binding.
Type IIP. Type IIP enzymes are the most ubiquitous and
varied of the Type II REases. They recognize symmetric
(palindromic) sequences and cleave symmetrically within
the sequence (e.g. EcoRI: G|AATTC) or, less often, at its
boundaries (e.g. EcoRII: |CCWGG). Almost always, Type
IIP REases are accompanied by one, and in rare cases
two, separateMTases of identical sequence specificity. Some
Type IIP REases act as monomers, but most act as ho-
modimers or homotetramers, and this structural duplica-
tion accounts for their symmetry in specificity and catal-
ysis. The multimers generally, but not always (383), cleave
both strands of the DNA duplex in the same binding event.
The monomers cleave DNA one strand at a time, but with-
out the release of nicked intermediate, indicating that the
same enzyme molecule cleaves both DNA strands at each
recognition sequence (133), first one strand and then the
other. Since these strands have opposite 5′ to 3′ orientations,
and the catalytic reaction is polarized, monomeric REases
must dissociate from the recognition sequence after the first
cleavage, rotate 180◦, and then re-associate in the opposite
orientation in order to cleave the second strand. This they
do without detaching from the DNA and returning to bulk
solution (133). A careful analysis of the reaction pathway
of the monomer BcnI (CC|SGG) showed that in a rapid
first step the enzyme hydrolyzes either strand, with a small
preference for the ‘G-strand’ (CCGGG) over the ‘C-strand’
(CCCGG); in a slow second step it slides away, rotates, and
then returns to the sequence in the other orientation; and
in a rapid final step it hydrolyzes the other strand. Much
of what we know about the monomeric Type IIP REases
comes from synergistic collaborations between Virginijus
Siksnys’ biochemistry group and Matthias Bochtler’s crys-
tallography group.
Type IIP recognition sequences are usually 4–8 spe-
cific base pairs in length. They can be continuous (e.g.
HindIII: A|AGCTT) or discontinuous, with one inter-
nal non-specific base pair (e.g. HinfI: G|ANTC), two
(e.g. Hpy188III: TCN|NGA), three (e.g. DraIII: CAC-
NNN|GTG), four (e.g. XmnI: GAANN|NNTTC), five (e.g.
BglIGCCNNNN|NGGC) ormore, up to a record nine (e.g.
XcmI: CCANNNNN|NNNNTGG), depending on the ge-
ometric relationship between the two subunits in the ho-
modimer. Cleavage can produce flush ends, or it can be
staggered and produce 5′- or 3′-overhangs of 1, 2, 3 or 4
bases, and occasionally more. Recognition sequences can
comprise a single base pair (e.g. XmaI: C|CCGGG; DraI:
TTT|AAA), or both base pairs, and many enzymes can ac-
commodate alternative base pairs at certain positions such
as R:Y (purine:pyrimidine = A:T or G:C), W:W (weak
base-pairing=A:T or T:A), S:S (strong base pairing=G:C
or C:G) andM:K (methylatable base=A:T or C:G) among
others.
Hundreds of different Type IIP specificities are known.
For each, usually several, and sometimes very many,
REases of identical specificity and similar amino acid se-
quence can be found in other bacteria and archaea. These
‘isoschizomers’ often represent diverged versions of the
same ancestral enzyme, the gene of which has moved later-
ally between prokaryotes and accumulated neutral changes
over time. Even among related enzymes, significant dif-
ferences in biochemical behavior have been noted (383).
Often, clusters of REases with closely related specificities
display clear amino acid sequence similarity––PstI (CT-
GCA|G) and SbfI (CCTGCA|GG), for example, or BssHII
(G|CGCGC) and AscI (GG|CGCGCC)––signifying recent
radiation from a common ancestor. REases with unrelated
specificities generally display no amino acid sequence sim-
ilarity, however, signifying either that no trace of common
ancestry remains due to the passage of time, or that they
arose independently to begin with. Aside from the hun-
dreds of different Type IIP REases that have been charac-
terized, the genes for thousands more have been identified
by bioinformatics analysis of sequenced microbial genomes
(see REBASE/REBASE Genomes for a current compila-
tion). These encode ‘putative’ (i.e. unverified) REases con-
sisting of isoschizomers, and likely novel enzymes with re-
lated, but as yet undiscovered, specificities. Type IIPREases
are symmetric, relatively small, and the least difficult to
crystallize. Most of the REases that have been crystallized
with substrate DNA belong to the IIP subtype, around 35
enzymes in all (Supplementary Table 2).
Type IIS. By definition, Type IIS REases cleave DNA at
fixed positions outside of their recognition sequence. Cleav-
age is shifted to one side of the sequence, within one or two
turns of the double helix away. Type IIS enzymes were first
discerned as being different by Waclaw Szybalski and col-
leagues at the University of Wisconsin (384), who devised a
variety of ingenious applications for them (385,386). FokI,
one of the earliest such enzymes discovered (387), is the
best known and is the source of the DNA-cleavage domain
used in synthetic gene-targeting endonucleases (388). Tech-
nically, all Type IIB, C and G REases (e.g. BcgI, Eco57I,
MmeI) are Type IIS enzymes, too, because they cleave out-
side of their recognition sequences. These form a close-knit
group centered on their core gamma-class MTase domain,
as described above. They are distinct from the rest of the
Type IIS enzymes, and are excluded from the discussion
that follows. FokI has been studied in some depth, and has
been crystallized with and without bound DNA (262,328–
329). Apart fromBfiI, which is very unusual (327), few other
Type IISREases have been studied in detail and, for want of
better understanding, FokI is considered representative of
the Type IIS subclass, although other kinds likely exist. In
Type IIP REases, the amino acids responsible for recogni-
 at Bibliothekssystem
 der U
niversitaet G
iessen on February 10, 2015
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
7510 Nucleic Acids Research, 2014, Vol. 42, No. 12
tion and for catalysis are integrated into one composite do-
main (268). In Type IIS REases, they occur in different do-
mains, which can be split into separate protein chains (389).
Type IIS REases are generally larger than Type IIP REases
and comprise an N-terminal, sequence-specific recognition
domain, a connecting ‘linker’ or ‘arm’, and a C-terminal
DNA-cleavage domain with no sequence specificity.
Type IIS recognition sequences are usually asymmetric.
In all likelihood this is not through necessity, but rather re-
flects the fact that far more asymmetric DNA sequences ex-
ist to be recognized than symmetric sequences. Because the
recognition sequence is asymmetric, cleavage takes place on
only one side. If it were symmetric, both sides would be-
come cleaved, first one and then the other. NmeDI (12/7
RCCGGY 7/12) is an example of just such a symmetric
Type IIS enzyme (325,390). FokI recognizes 5′-GGATG-
3′/5′-CATCC-3′ and catalyzes staggered cleavage 9 bases
away on one strand and 13 bases away on the other, pro-
ducing fragments with 4-base, 5′-overhangs. By convention,
the recognition sequence of Type IIS enzymes is written
in the orientation in which cleavage occurs to the right of
the sequence, downstream of what is then defined as the
‘top’ strand. Thus, the catalytic activity of FokI is written
‘GGATG 9/13’, by convention, rather than the equally ac-
curate, ‘13/9 CATCC’. Type IIS REases are usually accom-
panied by two separateMTases, each of which modifies one
strand of the recognition sequence by methylating one ade-
nine or one cytosine in that strand. Often, these MTases
occur as individual proteins, but sometimes, as is the case
in the FokI R–M system, they are joined into one protein
chain (391,392). The benefits of such fusions are unknown
but, all things being equal, it allows the MTases to be syn-
thesized in a fixed, 1:1 ratio and their synthesis to be co-
regulated. And, if the hemimethylated daughter DNA du-
plexes are re-methylated as they emerge from the replication
complex, whenever one MTase is needed to service one du-
plex, the otherMTase is on hand to service the other duplex.
A few Type IIS R–M systems include only one compan-
ionMTase, rather than two. These systems recognize quasi-
palindromic sequences that are viewed as asymmetric by the
REase, but symmetric (and ambiguous) by theMTase. As a
consequence, both strands of the recognition sequence be-
come modified by just the one MTase. Examples include
BbvI (REase: GCAGC 8/12; MTase: GCWGC) and MlyI
(REase: GAGTC 4/4; MTase: GASTC). There is a price to
be paid for methylation, and prokaryotes go to lengths not
to squander it. The Type IIS R-M system AlwI comprises
an REase (GGATC 4/5) and twoMTases joined into a sin-
gle chain, one specific for the top strand sequence, GGATC,
the other for the complementary bottom-strand sequence,
GATCC. A single MTase such as M.MboI, M.DpnII or
Dam (GATC) methylates both of these strands at the same
positions, and protects theAlwI sequence from cleavage just
as effectively as do its two, complementary MTases. How-
ever, they also methylate additional sequences (AGATC,
TGATC and CGATC) that are not necessary for protection
from AlwI, and the evolutionary cost of this has given the
two-MTase solution adopted by the AlwI R–M system the
selective edge.
FokI consists of an N-terminal DNA-binding domain
and a C-terminal, non-specific, cleavage domain (328). Like
other Type IIS REases that cleave more than a few base
pairs from their recognition sequence, the FokI cleavage
domain contains only one catalytic site, in this case of
the PD-D/EXK kind. Three important observations came
from the FokI structural studies that have guided think-
ing since not only about Type IIS REases but about Type
IIB, C and G REases, too. First, in FokI crystal structures,
the catalytic domain is ‘sequestered’ by the DNA-binding
domain in a position that is unfavorable for DNA cleav-
age. This suggests that the catalytic domain might be con-
trolled to prevent non-specific DNA cleavage, and that it is
restrained during linear diffusion/three-dimensional hop-
ping, and then released, perhaps due to a conformational
change in the DNA-binding domain, when the recogni-
tion site is acquired. (The Type IIP REase, SfiI (GGCC-
NNNN|NGGCC), cleaves within a 5 bp non-specific se-
quence, and so its catalytic sites also disregard the flank-
ing base pair sequence, much like the FokI catalytic sites.
In the crystal structure of SfiI with DNA, the catalytic sites
are too far from the DNA to initiate cleavage, exemplifying
perhaps another cleavage-control mechanism (393)). Sec-
ond, nicked DNA intermediate does not accumulate dur-
ing the FokI cleavage reaction, suggesting that an individ-
ual cleavage domain cannot catalyze strand-cleavage on its
own. And third, cleavage is stimulated by multiple recogni-
tion sites in the DNA, and by the addition of the purified
catalytic domain, suggesting that cleavage of duplex DNA
requires the dimerization of two catalytic domains (329).
Pieces of the cleavage puzzle are still missing and await
further experimentation, but the current idea is that double-
strand cleavage by Type IIS REases requires dimerization
of the catalytic domains of nearby molecules at least one of
which is specifically bound to a recognition site (329,378).
In some cases the second molecule can be free in solution
or bound to DNA non-specifically (394), but the complex
is more stable when it, too, is specifically bound (395,396).
If so, the two sites do not have to be nearby, or in any par-
ticular orientation, and if they are far apart, DNA looping
takes place between them (397,398). The requirement that
two enzymemolecules be specifically bound to interact pro-
ductively for catalysis could be another example of the ‘wait
and see’ precaution discussed earlier for Type IIE and IIF
enzymes. A surprisingly large number of Type II REases be-
have in this way, in fact, and require at least two recogni-
tion sites in order to cleave (399–401). In the case of FokI,
when molecules bound to two sites associate (‘synapse’),
the recognition sequences are held side-by-side, in paral-
lel (402). This is somewhat surprising because in order to
dimerize, the catalytic domains must assume opposite ori-
entations. It is easier to visualize this happening between
molecules that approach one another head-on, than side-
ways. Ultimately in the synapses, both bound DNA du-
plexes become cleaved. This suggests that the catalytic do-
mains can shift from one side to the other, cleaving first one
duplex and then moving over to cleave the other.
The co-crystal structure of FokI reveals how the DNA
interacts specifically with the binding domain (pdb:1FOK),
but not how it interacts with the cleavage domain(s) (262).
The alternative structure, in which the cleavage domains
are dimerized (pdb:2FOK), lacks DNA (328). In fact, for
all of the many REases we suppose dimerize transiently
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through their catalytic domains when they cleave DNA,
not a single structure revealing this event has been ob-
tained. Instead we rely on modeling. Modeling suggests
that when the FokI catalytic domain releases from its se-
questered position in the specific complex, the connecting
arm between the two domains opens approximately 180◦
by rotation around an ‘elbow’ centered roughly on amino
acid 385, and the catalytic site comes to rest in the cor-
rect position and orientation to cleave the bottom strand of
the DNA, 13 bp away. Using a clever combination of two
FokI mutant enzymes, one (D450A) binding-proficient but
catalysis-deficient, the other (N13Y) binding-deficient but
catalysis-proficient, Steve Halford’s group confirmed this
strand-specificity experimentally. When FokI binds to its
recognition sequence, they report, the catalytic site of the
boundmolecule cleaves the bottom strand at the ‘distal’ site
(+13), and the catalytic site of the recruitedmolecule cleaves
the top strand at the ‘proximal’ site (+9) (403). Whether
the same strand-specificity holds true for other Type IIS en-
zymes remains to be seen.
Type IIT. ‘Type IIT’ was intended for REases that act as
heterodimers, and comprise two different subunits. Among
the original examples, Bpu10I (CC|TNAGC) and Bb-
vCI (CC|TCAGC) fit this description (324,404–405), but
BslI (CCNNNNN|NNGG) is now known to be an al-
pha(2):beta(2) heterotetramer (23), and is better thought of
as an unusual Type IIP (palindromic) REase. Type IIT en-
zymes, today, are perhaps more usefully defined as REases
that have two different catalytic sites. Some of these en-
zymes are heterodimers (e.g. BbvCI; Bpu10I; BtsI, BsrDI
and BspD6I (406)). Others are single-chain proteins with
two distinct catalytic domains (e.g. Mva1269I (126); BtsCI
(407); AciI, BsrI, BssSI and BsrBI). All of these enzymes
recognize asymmetric sequences and cleave within, or very
close to, only one side of the sequence. In some cases, the
two subunits/domains are of similar size, and both partici-
pate in sequence recognition as well as in catalysis (e.g. Bb-
vCI; BmgBI). In others, the subunits/domains are of differ-
ent size, and the larger subunit recognizes the sequence in
its entirety and cleaves one strand, while the smaller subunit
lacks sequence specificity and just cleaves the second strand
(e.g. BsrDI; BtsI; BspD6I). In general, Type IIT REases are
accompanied by two separate MTases, one for modifying
each strand of their asymmetric recognition sequence. In
some systems, these MTases are individual proteins, in oth-
ers they are joined into a single protein chain. Because Type
IITREases, as defined here, have two different catalytic sites
they can be converted into strand-specific nicking endonu-
cleases by mutating one site or the other (127,324), or by
eliminating the small subunit (311). See Chan et al. for a
recent review (408).
Grouping by catalytic site. Despite the numerous forms
in which they occur, Type II REases are considered to
be variations on three catalytic themes, for the most part,
termed ‘PD-D/EXK’ (e.g. EcoRI), ‘HNH’ (e.g.KpnI (237))
and ‘GIY-YIG’ (e.g. Eco29kI (370)) for the amino acid
motifs that comprise their catalytic sites. These motifs re-
cur in other kinds of nucleases, including homing endonu-
cleases, Holliday-junction resolvases and exonucleases (8).
PD-D/EXK endonucleases were described in an earlier sec-
tion; we discuss the other kinds of catalytic sites here.
HNH enzymes. Based on bioinformatics analysis, the
next most common class of Type II REases after the
PD-D/EXK enzymes are the ‘HNH’ enzymes which in-
clude KpnI (GGTAC|C (237)), MboII (GAAGA 8/7),
SphI (GCATG|C) and several others (26). Non-specific en-
donucleases (e.g. the Serratia nuclease and colicins), hom-
ing endonucleases (e.g. I-PpoI and I-HmuI) and Holliday-
junction resolvases also belong to this class (409–411). The
catalytic residues of PD-D/EXK enzymes can sometimes
be recognized by eye in amino acid sequences, but those of
HNH enzymes rarely can since they vary, and are spread
out. Sokolowska et al. (238) describe the oftenweak connec-
tion that exists between ‘H-N-H’ and the residues that actu-
ally form these catalytic sites. The HNH catalytic residues
are sometimes embedded in a structure termed a  fold,
in which a zinc ion is coordinated by four cysteine residues
in two groups of two (CXXC. . .CXXC). The occurrence of
this motif within a sequence can be indicative of an HNH
catalytic site, as it is in Hpy99I (CGWCG|) (238), but this
is far from definitive. Many Cys4-Zn2+ motifs are not as-
sociated with catalytic sites, yet others are associated with
PD-D/EXK sites (e.g. DpnI) and variants (e.g. Vsr (412)).
In the context ofHNH sites, the Zn2+ ion is not catalytic but
rather acts to maintain the integrity of the fold. And unlike
conventional zinc-finger domains that function in DNA se-
quence recognition, those of HNH REases––there can be
more than one in each subunit––perform structural roles
unrelated to sequence recognition.
HNH REases require a divalent cation such as Mg2+ or
Mn2+ for catalysis and some, such as MnlI (CCTC 7/6)
(413) and HpyAV (CCTTC 6/5) (414), have been reported
to use a variety of other ions including Ni2+, Co2+, Zn2+
and even Ca2+. Why these serve for catalysis in HNH site
(and GIY-YIG sites, below) but not in PD-D/EXK sites
remains unclear. Only a single metal ion is present at the
catalytic sites in the crystal structures of Hpy99I (Na+) and
PacI (Ca2+), both Type IIP homodimers. It is coordinated
in the sameway in both, by six oxygen atoms: one each from
the side chains of Asp (D) and Asn (N), two from the target
phosphate (proS and the 3′-leaving oxygen), and two from
water molecules. In Hpy99I and other HNH sites, His (H)
is positioned on the 5′-oxygen side of the target phosphate
to act as the general base and assist in the creation of the
attacking hydroxide ion (415). In PacI (TTAAT|TAA), ty-
rosine is positioned to be the general base, instead. (22).
Despite an unfavorable pKa of 10, it seems plausible that
this tyrosine exists in the phenolate state (-O−) before DNA
binding, and reverts to the un-ionized state (-OH) by de-
protonating the nucleophilic water molecule when close to
negatively charged DNA phosphates.
GIY-YIG enzymes. A small number of REases including
Cfr42I (CCGC|GG), its isoschizomer Eco29kI (372), and
Hpy188I (TCN|GA) (240), use a third class of catalytic
site termed ‘GIY-YIG’ (26). The DNA co-crystal struc-
tures of Eco29KI and Hpy88I, both Type IIP homodimers,
have been solved (239). A single Na+ ion is present in the
Hpy188I catalytic site, coordinated by one amino acid side
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chain (Asp), three water molecules, and by two phosphate
oxygens––proS and the 3′-leaving group. This is same co-
ordination as occurs in the HNH REases discussed above,
except that an extra water molecule takes the place of the
second amino acid, Asn. Eco29kI crystallized without a
metal ion at the catalytic site but the organization is sim-
ilar. In both structures, the nucleophilic water molecule is
positioned and oriented to attack the phosphorus by H-
bonds to one main chain carbonyl oxygen and to the side
chain oxygen of the tyrosine of the first GIY motif. The lat-
ter is presumed to be in the phenolate (-O−) state and to act
as the general base much as in PacI, with assistance, per-
haps, from adjacent residues. Like HNHREases, GIY-YIG
REases can use a variety of divalent metals for catalysis in
addition to Mg2+ and Mn2+.
An interesting difference between the HNH and GIY-
YIG sites on one hand, and the PD-D/EXK sites on the
other, concerns the position of the metal ion. In the for-
mer, it contacts two oxygen atoms of the target phosphate
group, the proS non-bridging oxygen and the 3′ leaving oxy-
gen (238,241). In this position, the metal ion is beyond co-
ordination range of the nucleophilic water, which cannot
therefore originate from its hydration sphere. The invari-
ant metal ion of PD-EXK sites, on the other hand, con-
tacts only the non-bridging phosphate oxygen, and is of-
ten close enough to coordinate, and help orient, the nucle-
ophilic water. In PD-D/EXK sites in which as secondmetal
ion is present, it often occupies approximately the same po-
sition as the single metal ion of the HNH and GIY-YIG
sites, and is coordinated in a similar way to both phosphate
oxygens. The ability of HNH and GIY-YIG sites to use a
variety of metal ions for catalysis while PD-D/EXK sites
use only Mg2+, and occasionally Mn2+, might be related in
some way to the different placements and coordinations of
the ions.
Phospholipase D enzymes. The Type IIS enzyme BfiI
(ACTGGG 5-7/4) and its closely related isoschizomer,
BmrI, differ strikingly from other REases in both organiza-
tion and catalysis. They use a metal-independent catalytic
site, termed PLD belonging to the Phospholipase D super-
family, and they cleave DNA one strand at a time in an
unusual way involving a covalent enzyme–DNA interme-
diate (309). BfiI acts as a homodimer. The C-terminal half
of each subunit forms a DNA-binding domain, which re-
sembles B3-like plant transcription factors (416,417). The
dimer binds to two recognition sequences at once (418) but
has only one catalytic site, which is located at the interface of
the two N-terminal domains, as it is in the EDTA-resistant
Nuc endonuclease from Salmonella typhimurium (419).
BflI cleaves the bottom strand first (+4) and then,
more slowly and with some variability, the top strand. Its
catalytic site contains symmetrically disposed His105-X-
Lys107 (HXK) residues, typical of PLD enzymes, and ad-
ditional conserved catalytic residues including N125 and
E136. In the first step of the strand-hydrolysis reaction, one
of the His residues is proposed to act as the nucleophile,
while the other is proposed to act as a general acid to proto-
nate the 3′-O leaving group. This results in the formation of
a 3′-OH on one side of the break and a 5′-phospho-histidine
covalent intermediate on the other. In the second step, in-
line attack by a hydroxide, or some other nucleophile (309),
displaces the histidine and generates a 5′-phosphate, which
retains its original stereoconfiguration (327). The same cat-
alytic site then transfers to the topDNA strand to hydrolyze
that. In principle, since the catalytic site of BfiI is symmet-
ric, it should be able to accommodate the opposite polarity
of the top strand by switching the roles of the two histidines
and working in reverse, as was originally proposed (326).
Surprisingly, BfiI appears not to do this, and instead is re-
ported to swivel the catalytic site by 180◦ so that the same
residues perform the same reaction on both DNA strands
(327).
Although BfiI appeared unique when discovered (236),
PLD-typeREases are far from rare.REBASEBLASTanal-
ysis identifies several other isoschizomers of BfiI in addition
to BmrI, and over 40 putative enzymes that have the con-
served HXK catalytic residues but in all likelihood differ-
ent organizations and recognition sequences. One cluster of
related enzymes includes NgoFVII and AspCNI (GCSGC;
cleavage site variable), which have been partially character-
ized. It is easy to imagine these enzymes binding to their
quasi-symmetric recognition sequence as homodimers with
a single composite catalytic site. It will be interesting to see
whether this catalytic site is bi-directional and can work in
reverse, or if these enzymes detach, rotate and reattach in
order to hydrolyze both strands, much like the monomeric
Type IIP REases such as BcnI (133).
‘Half-pipe’ enzymes. The PabI nuclease (226 aa; GTAC)
was identified by bioinformatics analysis of the genome of
the archaeon Pyrococcus abyssi (420). Its genomic location
suggested it might mediate genetic rearrangements, and its
proximity to the gene for a companion MTase (421) im-
plied that it was a small, unremarkable, Type IIP REase.
PabI was found to cleave DNA in the absence of diva-
lent metal ions, and was reported to leave a 2-base, 3′-
overhang: GTA|C. Amino acid sequence analysis revealed
little similarity to other REases and, when crystallized with-
out DNA, its structure proved to be unique and was as-
signed its own fold, termed ‘half-pipe’ (422). The crystal
structure of PabI with specific DNA was solved very re-
cently, and shows why this enzyme is so unusual: it is not
an endonuclease, after all (423). PabI binds to its symmet-
ric recognition sequence as a homodimer, and flips all four
purines out from the helix, leaving the pyrimidines intra-
helical, but orphans. And rather than catalyzing phospho-
diester bond hydrolysis, PabI is a DNA-adenine glycosy-
lase. It leaves the phophodiester backbone intact, and in-
stead excises both adenine residues to create apurinic sites
opposite the thymines. At the high temperature at which P.
abyssi lives (95◦C), strand hydrolysis is thought to proceed
spontaneously following this de-purination (423). Close
isoschizomers of PabI are ubiquitous in strains of H. py-
lori (e.g. HpyJ99XII), and at the moderate temperature that
these organisms live (37◦C), strand hydrolysis is thought to
be catalyzed by apurinic-apyrimidinic endonuclease (424).
Surprisingly, not only does PabI not resemble REases, it
does not resemble N-glycosylases, either!
Thousands of Type II REases are known; hundreds have
been characterized but most have not. Bioinformatics anal-
ysis and structure-guided sequence alignments have allowed
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approximately two-thirds of these to be assigned to one or
other of the three main families, PD-EXK (267,425-426),
HNH (427) and GIY-YIG (428). More can be assigned to
the PLD-family or the PabI-group, but others cannot be as-
signed to any family and remain mysteries (26,363). They
could be fringe members of the conventional families that
have diverged beyond recognition or, like PabI, they could
be examples of new, as yet uncharacterized, folds andDNA-
degradation mechanisms.
Grouping by quarternary structure. Since the substrates of
REases are duplex DNA molecules, cleavage requires two
catalytic reactions, one for hydrolyzing each DNA strand.
Type II REase quarternary organizations can often be un-
derstood in terms of the different ways in which two cat-
alytic sites can be brought to act on opposite strands in
the vicinity of the same DNA sequence. REases that act as
dimers generally possess two catalytic sites; these are iden-
tical in homodimers such as HindIII and EcoRI, but dif-
ferent in heterodimers such as BbvCI and BsrDI (324,406).
Dimeric REases of both kinds usually cleave both DNA
strands in a single binding event. Some monomeric REases,
such as HinP1I (130) andMvaI (131), possess only one cat-
alytic site and cleave DNA in two steps, hydrolyzing one
strand and then the other immediately afterward. Surpris-
ingly, they do this without detaching from the DNA and
returning to bulk solution. Instead, they release the recog-
nition sequence after the first nick, and then randomly slide
along the DNA and rotate until the sequence is recaptured
in opposite orientation (133). Othermonomers, such as BsrI
(406) andMva1269I (127), represent single-chain fusions of
ancestral heterodimers. They possess two different catalytic
sites within the one polypeptide chain, and generally cleave
bothDNA strands in one binding event. These enzymes can
exhibit marked strand preference, such that one strandmust
be cleaved by one of the catalytic sites before the second can
be cleaved by the other catalytic site (127). Whether this is
due to a structural peculiarity of the second catalytic site,
or to a biochemical peculiarity in the way it catalyzes the
reaction, is not known.
Numerous Type II REases, including many members of
the Type IIS subclass, and essentially all members of the
Type IIB, C and G groups, possess only one catalytic site
and bind to their recognition sequence in an inactive form.
Activation is thought to occur by transient dimerization
of the catalytic domain with an identical catalytic domain
from a second enzyme molecule either bound to another
recognition site or, with lesser effect, unbound. Dimeriza-
tion activates both catalytic sites, and so these enzymes gen-
erally cleave both DNA strands at once without the release
of nicked intermediates. The need for transient dimerization
accounts for the low activity of many REases on substrates
with only one recognition site, and explains why activity of-
ten increases in the presence of oligos that contain the recog-
nition sequence.
Many restriction enzymes cleave DNA as multimers
bound to two recognition sequences at once. Such
widespread behavior must confer a significant selective ad-
vantage, one that has to do, perhaps, with carefully dis-
tinguishing host DNA that must be saved, from foreign
DNA that must be destroyed. REases that cleave by tran-
sient dimerization automatically monitor two sequences at
once when both members of the partnership are bound
to DNA specifically. This might be the underlying reason
why so many REases operate in this way instead of sim-
ply acquiring a second catalytic site, a trivial step in evo-
lutionary terms. REases that bind to their recognition se-
quences as homodimers already have both catalytic sites
needed for cleavage. Some, such as NgoMIV and SfiI, nev-
ertheless monitor two recognition sequences at once by as-
sembling into tetramers of two back-to-back homodimers.
Viewed end-on, the two duplexes in these tetramers cross
each other at an angle of 60◦ in an ‘X’ configuration, and
both are cleaved at the same time (359).
Protein engineering of REases––tools for gene targeting
REase variants. Soon after the structure of the EcoRI–
DNA complex was determined (247), attempts were made
to change the specificity of EcoRI by substituting the amino
acids involved in base-specific interactions (for example
(254)). Substitutions were made according to suggestions
a decade earlier that certain amino acids were ideally suited
to juxtapose certain bases due to H-bond complementar-
ity. Asparagine and glutamine were ideal for adenine, it was
proposed, and arginine was ideal for guanine (91). These
particular juxtapositions and several others (429) are com-
mon in sequence-specific DNA-binding proteins, we now
know, and represent a ‘recognition code’ of sorts, albeit one
that is so variable due to alternative amino acids, and H-
bonds with atoms of the protein main chain, that it has little
predictive power. The substitutions introduced into EcoRI
and EcoRV, and subsequently into other REases, usually re-
sulted in a decrease in activity, but without exception failed
to produce substantial changes in specificity. The reason for
these failures has become clearer with time: recognition is
a highly cooperative and redundant process, involving not
only amino acids in direct contact with the bases and the
backbone, but also structured water molecules and an in-
tricate network of buttressing interactions (306). Even for
very well characterized REases, the properties that deter-
mine specificity and selectivity are difficult to model with
the available structural information (430). Furthermore, the
crystal structure of the recognition complex represents a
form of the ‘ground state’, but catalysis involves the ‘transi-
tion state’, which may depend upon additional interactions
not evident in the crystal structure.
In order to change specificity, the functional groups
of amino acids must be positioned in three dimensions
within the DNA-binding site in precise complementarity
with the bases they are to juxtapose. This demands struc-
tural accuracy far beyond what can be achieved by gross
amino acid substitutions. Notwithstanding, some Type IIG
combined RM enzymes have evolved DNA-binding do-
mains with C-alpha structures that allow them to undergo
specificity changes naturally at certain base pair positions.
Such changes confer a selective advantage because it al-
lows prokaryotes to side-step the resistance to restriction
that constantly evolves among its viruses. Almost invari-
ably, these changes in specificity involve switches of two
amino acids at once––one for each base of the base pair––
and they can be replicated in the laboratory by site-specific
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mutagenesis to achieve robust changes of specificity. For ex-
ample, in the MmeI-family of highly homologous RM en-
zymes that recognize 6–8 bp asymmetric sequences, speci-
ficity for GC at certain positions can be routinely changed
to CG, and vice versa, by substituting Glu. . .Arg (E. . .R)
pairs for Lys. . .Asp (K. . .D) pairs, and certain other equiv-
alent amino acid combinations (374).
REases normally produce a double-strand cut, but a few
can be altered to cut only one strand––to ‘nick’ the DNA,
that is (see Chan et al. (408) for a recent review). Nick-
ing enzymes are useful for a variety of DNA manipula-
tions, including the preparation of substrates for DNA re-
pair studies (431), the generation of DNA molecules with
long overhangs or with gaps, and the creation of 3′-OH
termini for labeling, for genomic mapping by optical bar-
coding, and for isothermal DNA amplification. Nicking en-
zymes can be isolated as the principal (large) subunits of
some heterodimeric REases (324,406,432–433), or they can
be engineered by generating homodimers (434–436) or het-
erodimers (324) with one active catalytic site and one in-
active catalytic site (435). The former enzymes are unusual
because their catalytic sites can act alone. BstNBI (GAGTC
4/5±), for example (and the identical BspD6I), comprises
two subunits of different size and function (311). One (604
aa) recognizes the DNA and contains the catalytic site for
top-strand hydrolysis; the other (186 aa) contains the cat-
alytic site for variable hydrolysis of the bottom strand. In
the presence of both the subunits, the DNA is cleaved (432),
but in the presence of only the large subunit (‘Nt.BstNBI’),
the DNA is efficiently and accurately nicked in only the top
strand (433,437). The catalytic sites of most Type IIS en-
zymes are inactive unless dimerized, whereas the top-strand
catalytic site of BstNBI is active either way.
The break-through with fusion proteins. Type II REases are
among the most specific enzymes known. On average, they
recognize and cleave one site every 1 × 4n base pairs for
symmetric sequences, and 2 × 4n base pairs for asymmet-
ric sequences, where n is the length of the recognition se-
quence, typically 4–8. For precise gene targeting in the com-
plex genomes of eukaryotes, only a single cut at a defined
location is desirable. Achieving this degree of specificity re-
quires a recognition sequence of about 20 bp in length.
To accomplish this, Srinivasan Chandrasegaran at Johns
Hopkins School of Medicine pioneered a new approach of
‘modular design and assembly’ (438). Analysis of the Type
IIS REase, FokI (GGATG 9/13), showed that the enzyme
was organized in a different way than EcoRI and EcoRV.
Whereas the catalytic and recognition residues of the lat-
ter are integrated into a single protein domain, in FokI
they are separate. FokI has an N-terminal DNA-binding
domain (BD), and a C-terminal, non-specific, cleavage do-
main (CD) that hydrolyzes DNA outside of the recognition
sequence roughly one turn of the helix away (389,439-442).
Changdrasegaran’s group constructed novel fusion proteins
consisting of DNA-binding modules from eukaryotic pro-
teins joined to the FoKI CD module (388). Their most suc-
cessful fusion used the DNA-binding domain from a zinc
finger protein joined to the FokI CD to create what is now
termed a ‘zinc finger nuclease’ (ZFN) (438). ZFNs typically
contain a series of three to six zinc fingers. Each zinc finger
comprises ∼30 aa that fold into a characteristic  struc-
ture that coordinates one Zn2+ ion via two cysteine and two
histidine residues (443,444). Each zinc finger recognizes a
three base pair target sequence through four contact amino
acids that project from the  helix into the major DNA
groove (445,446) (Figure 13).
The use of zinc fingers as specific DNA-binding mod-
ules offers the advantage that they are ‘programmable’. The
specificities of individual fingers can be changed to some ex-
tent by mutagenesis, and the order of the fingers in an array
can be changed at will by gene synthesis. In principle, almost
any sequence in a complex genome can be targeted with a
carefully selected zinc finger array, although in practice this
is easier said than done. The non-specific FokI cleavage do-
main of ZFNs does not contribute to specificity, but it has
a property that greatly enhances the accuracy and utility
of ZFNs. On its own, the FokI CD is inactive. In order to
cleave DNA, two CDs from oppositely oriented molecules
must dimerize transiently (329). Positioning two CDs close
together on DNA increases the likelihood that this will oc-
cur. In FokI-based ZFNs, two separate zinc finger arrays
are designed to bind to adjacent sites in the DNA in op-
posite orientations. With two different three-finger ZFNs,
a 2 × (3+3+3) = 18-bp sequence that is unique in the hu-
man genome can be recognized and cleaved (447). Pairs of
ZFNs have been used with considerable success in this way
for gene targeting (448–450), although evidence ismounting
that they are not as specific as might be expected (451,452),
and that cleavage at unintended sites also occurs. Part of
this ‘off-target’ cleavage is due to homodimer formation,
and can be reduced by mutating the amino acids of the
CD dimerization surface (453,454). Part might also be due,
as pointed out by Halford et al., to dimerization between
a specifically bound ZFN and one that is not specifically
bound. The FokI CD is inherently compromised, they sug-
gest, because its dimerization mechanism does not preclude
off-site targeting (395). Recently, a novel zinc-finger nucle-
ase platform was described using a derivative of PvuII as a
sequence-specific catalytic domain instead of the FokI CD.
PvuII adds an extra element of specificity when combined
with zinc fingers, and ZF-PvuII nucleases are designed such
that a PvuII site (CAG|CTG) occurs naturally between the
two ZF-binding sites. In contrast to the ‘analogous’ ZF-
FokI nucleases, neither excess enzyme over substrate nor
prolonged incubation times results in off-target cleavage by
ZF-PvuII nuclease pairs in vitro (455).
The design and selection of zinc finger arrays to make
pairs of ZFNs for gene targeting is complex and costly. Af-
ter the DNA-binding domains of transcription activator-
like effector (TALE) proteins were shown to be modular,
and to recognize DNA in a simple 1 module:1 base fash-
ion (456,457), they began to be used instead of ZF arrays to
engineer programmable nucleases for gene targeting. Natu-
ral TALE proteins contain a variable number (up to 35) of
nearly identical, ∼34 aa tandem repeats. The amino acid
at position 13 in each repeat (the second residue of the
‘repeat-variable di-residue’ or RVD) is responsible for base-
recognition. The repeat arrays form a right-handed super-
helix that spirals around the DNA with astonishing ele-
gance, following the track of the major groove for several
turns. The individual repeats are left-handed two-helix bun-
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Figure 13. Mode of DNA binding by zinc finger proteins: each finger recognizes approximately three base pairs of the recognition sequence. For one zinc
finger the amino acids forming essential base contacts (residues at positions 1, 2, 3, 6 of each helix) are shown in purple.
dles that, one after the other, juxtapose aa 13 of each RVD
to adjacent bases in the sense strand of the DNA (458–460),
(Figure 14).
Because of their simple design, predictable sequence
specificity and ease of synthesis, TALE-based nucleases
(TALENs) have largely replacedZFNs as the tools of choice
for genome engineering. So far, TALEs have been used
mainly in conjunction with the FokI CD (461,462). It re-
mains to be seen whether TALENs are less prone to off-
target cleavage than ZFNs (463) and whether alternative
DNA-cleavage modules from other Type II REases can of-
fer advantages over the cleavage domain of FokI (464,465).
Gene targeting requires precisely positioned incisions in
genomic DNA in order to stimulate repair by homology-
directed genetic recombination (HR). It has been argued
that it might be better to cut only one DNA strand for
this purpose, using a nicking domain rather than a cleavage
domain, as this would decrease competing repair by error-
prone, non-homologous end joining (NHEJ) (408). Such
engineered nickases have been used in conjunctionwith zinc
fingers (466–468), TALE proteins (465) and methyl CpG
binding domains (469), and are proving to be very effective.
Epilogue
Type II REases have come of age. In doing so, they have
changed the landscape of molecular biology in ways barely
imaginable a few decades ago. It all started with the ob-
servation that phage sometimes infect new bacteria very
poorly. What might have been dismissed as just a nuisance
was studied instead and grew into the microbial field of
‘host-controlled restriction and modification’, an academic
curiosity of little broader significance. But as its underly-
ing biochemistry emerged, in the hands of a few skilled sci-
entists, the use of ‘restriction enzymes’ as laboratory tools
for DNA analysis and experimentation began to be con-
sidered. As Louis Pasteur said in a lecture delivered at the
University of Lille (7 December 1854), ‘Dans les champs
de l’observation le hasard ne favorise que les esprits pre-
pares’ (‘In the fields of observation chance favors only the
prepared mind’). Fueled by the subsequent discovery of
the Type II enzymes in the early 1970s, and by the in-
ventions of gene cloning and mapping, a revolutionary
new technology––‘Recombinant DNA’––sprang into being.
This technology has since transformed the life sciences and
medicine, and has seeded a multitude of enterprises, large
and small (43). To Type II REases we owe many billions of
dollars of economic activity, thousands of jobs and careers,
and staggering advances in knowledge and understanding.
Few examples as this speak so clearly of the importance to
society of investments in unencumbered, curiosity-driven,
basic research. To quote Pasteur once more ‘Il n’existe pas
de cate´gorie de science qui puisse eˆtre de´signe´e comme e´tant
applique´e’. Il y a la science et les applications de celle-ci,
re´unies comme le sont le fruit et l’arbre qui le porte’ (1871).
(‘There does not exist a category of science to which one can
give the name applied science. There is science and its appli-
cations, bound together as the fruit of the tree that bears it’.)
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SUPPLEMENTARY FIGURE & TABLE LEGENDS 
 
Supplementary Figure S1. Procedures used for cloning R-M systems. Plasmid libraries are 
prepared and digested with the restriction enzyme whose gene is sought (middle flow diagram). 
The digests are used to transform E.coli, and survivors are screened individually, or pooled and 
cycled through a second round of digestion. This ‘methylase selection’ yields complete R-M 
systems sometimes, but more often only the M gene. The libraries can be exposed to phage to 
select for cells that carry the complete R-M system and are able to restrict, but this method is 
unreliable. When only the M gene is isolated, adjacent fragments can be identified and analyzed 
and the R gene recovered non-selectively. N-terminal amino acid analysis of the purified REase, 
and internal tryptic peptide analysis, are helpful in these cases (right flow diagram). Increasingly, 
R-M systems are now identified by whole-genome sequencing using 454- and PacBio-machines 
and bioinformatics analysis (left flow diagram). The systems are then retrieved by PCR or gene 
synthesis. PacBio is particularly useful in this regard because it delivers the gene sequences, 
and also often the recognition sequence and the position of DNA modification (1). Cloning R-M 
systems has brought two major benefits: better, cheaper, laboratory reagents for DNA 
manipulation, and extensive insight into the organizations, evolution and biochemistry of the 
proteins involved. 
Supplementary Table 1. R-M systems cloned at New England Biolabs, Inc., 1981-2013. The 
list is not exhaustive, and Type IV systems are omitted. The table is organized according to the 
research group responsible for the cloning. Some projects involved more than one group 
resulting in duplicate table entries. Several entries repeat published work reported by others. 
Some projects spanned several years; the date generally refers to the cloning of the REase 
gene. Some dates are estimates. The sequences of most of the systems are available in 
REBASE and GenBank, although many have not been formally reported in the scientific 
literature. Group A: Geoff Wilson, Donald Nwankwo, Chuck Card, Rebecca Croft, Keith 
Lunnen, Tineka Jager,  Elizabeth Van Cott, Russ Camp, Shu-Zi Chen, Janet Barsomian, Mary 
Looney, Barton Slatko, Laurie Moran, Bo-Hong Zhang, Marta Meda, Dan Heiter, Jonathan 
O'Driscoll, Hua Wang. Group B: Rich Roberts, Iain Murray, Alexy Fomenkov, Rick Morgan, 
Brian Anton, Juliane Krebes. Group C: Joan Brooks, Kim Howard, Karen Silber, Laura Sznyter, 
Peter Nathan, Brian Anton. Group D: Shuang-yong Xu, Jian-Ping Xiao, Jim Samuelson, Alexey 
Fomenkov, Zhenyu Zhu, Siu-Hong Chan. Group E: Rick Morgan, Carol Polisson, Yvette 
Luyten. Group F: Zhenyu Zhu, Shengxi Guan, Aine Quimby, Janine Borgaro. ‘454’ and ‘Pac’ 
refer to systems identified by bioinformatics analysis of 454 and Pac Bio genome sequencing 
projects under the direction of group B. ‘CSH’ refers to clones isolated or analyzed at Cold 
Spring Harbor Laboratory (2,3). 
Supplementary Table S2. Restriction enzyme-DNA co-crystal structures solved by X-ray 
crystallography. Enzymes crystallized without DNA are omitted. Column 1: year the structure 
was published. Column 2: name of the enzyme. Column 3: the DNA sequence recognized and 
the position of cleavage (‘|’). PabI (last entry) acts as a sequence-specific DNA-adenine N-
glycosylase rather than an endonuclease; catalysis creates apurinic sites that are thought to 
undergo phosphodiester bond hydrolysis spontaneously (*). Most recognition sequences are 
symmetric and cleavage occurs at the same position on the complementary strand. Column 4: 
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the oligomeric form in which the enzyme cleaves DNA. ‘1’: binds to recognition sequence and 
cleaves as a monomer; ‘1-2’: binds as monomer but dimerizes transiently to accomplish 
cleavage; ‘2’: binds and cleaves as a homodimer; ‘2-4’: binds as a homodimer, but cleaves as a 
dimer of dimers. Column 5: publication reporting the structure.  
Supplementary Table S3. Approximate numbers of Type II REases in each subtype as 
described in the text. Adapted from REBASE (May 24, 2014). Subtypes P, A, C, G, S, and M 
include both characterized enzymes, and putative enzymes identified by bioinformatics analysis 
of sequenced genomes and meta-genomic samples. Some of the subtype M enzymes included 
here might better be classified as Type IV REases. Subtypes H, T, B, E, and F include only 
characterized REases. Among these, subtypes B, E and F are probably far more common than 
the numbers shown here suggest. 
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Supplementary Figure S1. R-M system cloning workflow 
Enzyme Recognition Sequence Year 
PstI CTGCAG 1981 
PstII CATCAG 25/27 1981 
EcoRI GAATTC 1982 
FokI GGATG 9/13 1983 
HaeII RGCGCY 1983 
HaeIII GGCC 1983 
HhaI GCGC 1983 
HhaII GANTC 1983 
HinfI GANTC 1983 
MspI CCGG 1983 
BamHI GGATCC 1984 
BanI GGYRCC 1984 
DdeI CTNAG 1984 
HgaI GACGC 1984 
HgiAI GWGCWC 1984 
HindII GTYRAC 1984 
HindIII AAGCTT 1984 
TaqI TCGA 1984 
AluI AGCT 1985 
BanII GRGCYC 1985 
BglI GCC N5 GGC 1985 
FnuDII CGCG 1985 
FnuDIII GCGC 1985 
HpaII CCGG 1985 
NlaIII CATG 1985 
NlaIV GGNNCC 1985 
SalI GTCGAC 1985 
AvaI CYCGRG 1986 
AvaII GGWCC 1986 
FnuDI GGCC 1986 
AatII GACGTC 1987 
AccI GTMKAC 1987 
Afl II CTTAAG 1987 
HinP1I GCGC 1987 
NaeI GCCGGC 1987 
NcoI CCATGG 1987 
XbaI TCTAGA 1987 
AvrI CYCGRG 1988 
AvrII CCTAGG 1988 
BalI TGGCCA 1988 
BstYI RGATCY 1988 
MwoI GC N7 GC 1988 
SacII CCGCGG 1988 
Sau96I GGNCC 1988 
SmaI CCCGGG 1988 
SphI GCATGC 1988 
XmaI CCCGGG 1988 
XmaIII CGGCCG 1988 
Enzyme Recognition Sequence Year Note 
Afl III ACRYGT 1989 
BbvI GCAGC 8/12 1989 
NciI CCSGG 1989 
SfiI GGCC N5 GGCC 1989 
AmeI GTGCAC 1990 
AmeII GCCGGC 1990 
BfaI CTAG 1990 
EarI CTCTTC 1/4 1990 
AciI CCGC 1991 
ApoI RAATTY 1991 
AscI GGCGCGCC 1991 
SfaNI GCATC 5/9 1992 
Tsp509I AATT 1992 
KasI GGCGCC 1992 
MscI TGGCCA 1993 
AgeI ACCGGT 1994 
AhdI GAC N5 GTC 1994 
BsrI ACTGG 1/-1 1994 
RsaI GTAC 1994 
SnaBI TACGTA 1994 
BlpI GCTNAGC 1995 
BsrBI CCGCTC 1997 
EaeI YGGCCR 1997 
AclI AACGTT 1998 
Bsu36I CCTNAGG 1999 
AlwI GGATC 4/5 1999 
BbvCI CCTCAGC 2000 
BssSI CACGAG 2000 
Cac8I GCNNGC 2000 
SfoI GGCGCC 2000 
DrdI GAC N6 GTC 2001 
MluCI AATT 2001 
SbfI CCTGCAGG 2002 
BmrI ACTGGG 5/4 2002 
CspCI 10/12 CCAC N5 TTG 12/10 2003 
Acc65I GGTACC 2004 
BssIMI GGGTC -3/0 2004 
AleI CAC N4 GTG 2005 
AfeI AGCGCT 2006 454 
BstNBI GAGTC 4/4 2006 
BspDI ATCGAT 2007 454 
BssKI CCNGG 2007 454 
BstXI CCA N6 TGG 2007 
NcuI GAAGA 8/7 2007 454 
NgoAVIII 10/12 TCA   N5 GTC 13/11 2007 
SdeOSI 10/12 TCAY N4 GTC 13/11 2007 
BtgZI GCGATG 10/14 2008 454 
PvuI CGATCG 2008 
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Group A 
4 
Enzyme Recognition Sequence Year Note 
BsuRI GGCC 1985 CSH 
MspI CCGG 1989 CSH 
TspMI CCCGGG 2007 
BsaHI GRCGYC 2008 
Hpy188I TCNGA 2000 
AbaCI CTATCAV 2010 
DrdVI GCAGCC 2011 
CjeFIII GCAAGG 2012 Pac 
CjeFV GGRCA 2012 Pac 
CjeNIII GKAAYG 19/17 2012 Pac 
Hpy99XIII GCCTA 2013 Pac 
Hpy99XIV GGWTAA 2013 Pac 
HpyAXIV GCGTA 2013 Pac 
HpyAXVIII ACA N8 TAG 2013 Pac 
Mba11I AGGCGA 2013 Pac 
Nal45188II ACCAGC 2013 Pac 
Plu4II CGTARC 2013 Pac 
SstE37I CGAAGAC 20/18 2013 Pac 
Cal14237I 	  GGTTAG 2014 Pac 
DvuIII CACNCAC 2014 Pac 
Hpy99XIII GCCTA 2014 Pac 
PaePA71 GAGGAC 2014 Pac 
Enzyme	   Recogni3on	  Sequence	   Year	  
DdeI	   CTNAG	   1985	  
BamHI	   GGATCC	   1986	  
BglII	   AGATCT	  
SphI	   GCATGC	  
EagI	   CGGCCG	  
SacII	   CCGCGG	  
XhoI	   CTCGAG	  
XhoII	   RGATCY	  
Group B	   Group C	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Enzyme Recognition Sequence Year Note 
BsrGI TGTACA 2002 
BtsI GCAGTG 2/0 2003 
BtsCI GGATG 2/0 2003 
N.CviPII CCD 2003 
PhoI GGCC 2003 
TmaI CGCG 2003 
ApeKI GCWGC 2004 
BpuSI GGGAC 10/14 2004 
BsmFI GGGAC 10/14 2004 
CviAII CATG 2004 
CviKI-1 RGCY 2004 
CviQI GTAC 2004 
Eco53KI GAGCTC 2004 
AsiSI GCGATCGC 2005 
BsrDI GCAATG 2/0 2005 
EcoNI CCT N5 AGG 2005 
N.CviQII RAG 2005 
NarI GGCGCC 2005 
NruI TCGCGA 2005 
StuI AGGCCT 2005 
Tth111II CAARCA 11/9 2005 
BmrI ACTGGG 2006 
BspQI GCTCTTC 1/4 2006 454 
BceSI CGAAG 25/27 2008 
BceSIII ACGGC 12/14 2008 
BcoDI GTCTC 2008 
CatHI CTCTTC 1/4 2009 
HpyAV CCTTC 6/5 2009 
SauUSI SCNGS 2009 
N.φGamma ACCGR 2011 
N.BceSVIII AYSS 2011 
BsaXI 9/12 AC N5 CTCC 10/7 2012 
BisI Gm5CNGC 2012 
FspCI ACCTGC 4/8 2013 
Enzyme Recognition Sequence Year 
AatII GACGTC 1992 
EcoO109I RGGNCCY 1992 
BsoBI CYCGRG 1993 
TfiI GAWTC 1993 
Tth111I GAC N3 GTC 1993 
ApaLI GTGCAC 1994 
MfeI CAATTG 1994 
SacI GAGCTC 1994 
ScaI AGTACT 1994 
SapI GCTCTTC 1/4 1995 
BssHII GCGCGC 1996 
BslI CC N7 GG 1996 
BspHI TCATGA 1996 
TseI GCWGC 1996 
Tsp45I GTSAC 1996 
AgeI ACCGGT 1997 
NspI RCATGY 1997 
BsrFI RCCGGY 1998 
NheI GCTAGC 1998 
NspHI RCATGY 1998 
OkrAI GGATCC 1998 
BpmI CTGGAG 16/14 1999 
BsaJI CCNNGG 2000 
BsmI GAATGC 1/-2 2000 
BstYI RGATCY 2000 
TspRI CASTG 2000 
BsmBI CGTCTC 1/5 2000 
BseRI GAGGAG 10/8 2000 
BsaI GGTCTC 1/5 2001 
PpuMI RGGWCCY 2001 
BsaWI WCCGGW 2001 
BsmAI GTCTC 1/5 2001 
MspAI1 CMGCKG 2001 
AcuI CTGAAG 16/14 2002 
Group D	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Enzyme Recognition Sequence Year 
NlaI  GGCC 1989 
NlaIII  CATG 1989 
NlaIV  GGNNCC 1989 
NotI  GCGGCCGC 1992 
BspMI  ACCTGC 4/8 1993 
FseI  GGCCGGCC 1994 
RsrII  CGGWCCG 1994 
MseI  TTAA 1996 
BccI  CCATC 4/5 1995 
Fnu4HI  GCNGC 1995 
MboI  GATC 1995 
MboII  GAAGA 8/7 1995 
PshAI  GAC N4 GTC 1995 
PacI TTAATTAA 1996 
PmeI  GTTTAAAC 1996 
SpeI  ACTAGT 1996 
PspGI  CCWGG 1997 
AseI  ATTAAT 1998 
AseII  CCSGG 1998 
Hpy99I  CGWCG 1999 
Hpy188I  TCNGA 1999 
Hpy188III TCNNGA 1999 
HpyCH4III  ACNGT 1999 
HpyCH4IV  ACGT 1999 
HpyCH4V  TGCA 1999 
MjaI CTAG 1999 
MjaIII GATC 1999 
MjaIV GTNNAC 1999 
MjaV GTAC 1999 
EsaBC3I TCGA 2000 
AspCNI GCSGC 2001 
BspCNI CTCAG 9/7 2001 
BstEII  GGTNACC 2002 
BseYI  CCAGC 2005 
FatI  CATG 2006 
Enzyme Recognition Sequence Year Note 
Type IIG RM Enzymes 
MmeI      TCCRAC 20/18 2001 
CstMI     AAGGAG 20/18 2003 
DraRI   CAAGNAC 20/18 2006 
EsaSSI     GACCAC 20/18 2006 
NlaCI      CATCAC 19/17 2006 
NmeAIII     GCCGAG 21/19 2006 
PspOMII   CGCCCAR 20/18 2006 
SdeAI     CAGRAG 21/19 2006 
SpoDI  GCGGRAG 20/18 2006 
ApyPI      ATCGAC 20/18 2007 
CdpI     GCGGAG 20/18 2007 
DrdIV      TACGAC 20/18 2007 
PspPRI      CCYCAG 21/19 2007 
MaqI   CRTTGAC 20/18 2008 
NhaXI   CAAGRAG 20/18 2008 
PlaDI      CATCAG 21/19 2008 
RpaB5I  CGRGGAC 20/18 2008 
AquII  GCCGNAC 20/18 2009 
AquIII     GAGGAG 20/18 2009 
AquIV  GRGGAAG 20/18 2009 
AteTI              GGGRAG     2009 
CcoMI         CAGCAG      2009 
GauT27I   CGCGCAGG  2009 
HauII   TGGCCA   11/9 2009 
Mae7806I     AAGGAG  2009 
MchCM4I     GAGGAG 20/18 2009 
PliMI        CGCCGAC 2009 
RceI   CATCGAC 20/18 2009 
CchII 2010  GGARGA   11/9 2010 
CchIII     CCCAAG 20/18 2010 
RdeGBI     CCGCAG 2010 
RdeGBII      ACCCAG 20/18 2010 
RlaII      ACACAG 2010 
RpaI   GTYGGAG 11/9 2010 
RpaBI  CCCGCAG 20/18 2010 
RpaTI  GRTGGAG 20/18 2010 
Sno506I  GGCCGAG 2010 
DprMRI  GCCCCAG 2011 
NflHI    GCGGAG 2011 
RflFIII     CGCCAG 2011 
RmuAI     CCCGAC 2011 
WviI     CACRAG 2011 
Cgl13032I  GGCGCA 2012 
Group E	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Enzyme Recognition Sequence Year Note 
AlwNI CAG N3 CTG 2006 454 
BmtI GCTAGC 2006 454 
Bpu10I CCTNAGC 2006 
BsaHI GRCGYC 2006 
Hpy166II GTNNAC 2006 
MslI CAY N4 RTG 2006 454 
PciI ACATGT 2006 454 
PspXI VCTCGAGB 2006 454 
ZraI GACGTC 2006 454 
Bme1580I GKGCMC 2007 
BciVI GGATAC 6/5 2007 
BspKT6I GATC 2007 
BstBI TTCGAA 2007 
BstZ17I GTATAC 2007 
FauI CCCGC 4/6 2007 
NarI GGCGCC 2007 454 
PspOMI GGGCCC 2007 454 
PsiI TTATAA 2007 
SmlI CTYRAG 2007 454 
BscAI GCATC 4/6 2008 
BsiHKAI GWGCWC 2008 
BsrBI CCGCTC 2008 
BmgBI CACGTC 2009 454 
Bsp1286I GDGCHC 2009 
BspUI GCSGC 2009 454 
BstAPI GCA N5 TGC 2009 454 
BstNI CCWGG 2009 454 
PflFI GAC N3 GTC 2009 454 
TseI GCWGC 2009 
BaeI 10/15 AC N4 GTAYC 12/7 2011 454 
BaeGI GKGCMC 2011 
BbsI GAAGAC 2/6 2011 454 
BsaBI GAT N4 ATC 2011 454 
BsiEI CGRYCG 2011 
EciI GGCGGA 11/9 2011 454 
BsgI GTGCAG 16/14 2012 
Cac8I GCNNGC 2012 
DrdI GAC N6 GTC 2013 454 
Group F	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Supplementary Table S2. Restriction Enzyme-DNA Co-Crystal Structures 
Year Enzyme Recognition 
sequence 
Active 
form 
Reference 
1986; 1990 EcoRI G|AATTC 2 (4),(5) 
1993 EcoRV GAT|ATC 2 (6) 
1994 PvuII CAG|CTG 2 (7) 
1995 BamHI G|GATCC 2 (8) 
1997 FokI GGATG 9/13 1-2 (9) 
1998 BglI GCCNNNN|NGGC 2 (10) 
1999 MunI C|AATTG 2 (11) 
2000 BglII A|GATCT 2 (12) 
2000 NaeI GCC|GGC 2 (13) 
2000 NgoMIV G|CCGGC 2-4 (14) 
2001 BsoBI C|YCGRG 2 (15) 
2004 HincII GTY|RAC 2 (16) 
2004 BstYI R|GATCY 2 (17) 
2005 EcoO109I RG|GNCCY 2 (18) 
2005 HinP1I G|CGC 1 (19) 
2005 MspI C|CGG 1 (20) 
2005 SfiI GGCCNNNN|NGGCC 2-4 (21) 
2006 Ecl18kI |CCNGG 2-4 (22) 
2007 BcnI CC|SGG 1 (23) 
2007 MvaI CC|WGG 1 (24) 
2008 BpuJI CCCGT 1-2 (25) 
2008 NotI GC|GGCCGC 2 (26) 
2008 PspGI |CCWGG 2 (27) 
2008 SgrAI CR|CCGGYG 2-4+ (28) 
2009 EcoRII |CCWGG 2 (29) 
2009 HindIII A|AGCTT 2 (30) 
2009 Hpy99I CGWCG| 2 (31) 
2010 Eco29KI CCGC|GG 2 (32) 
2010 PacI TTAAT|TAA 2 (33) 
2011 Hpy188I TCN|GA 2 (34) 
2011 OkrAI G|GATCC 2 (35) 
2011 ThaI CG|CG 2 (36) 
2012 Bse634I R|CCGGY 2- 4 (37) 
2012 DpnI Gm6A|TC 1 (38) 
2014 BfiI ACTGGG 5/4 2 (39) 
2014 PabI GTA*C 2 (40) 
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Supplementary Table S3. Occurrences of Type II subtypes 
Type II
Subtype
Definition from Roberts et al. 2003 [37]
Not all subtypes are mutually exclusive
No. of enzymes 
listet in REBASE
P Symmetric target and cleavage sites 8697
A Asymmetric recognition sequence 6230
C
Symmetric or asymmetric target. R and M functions in one 
polypeptide
4960
G Symmetric or asymmetric target. Affected by AdoMet 4954
S Asymmetric target and cleavage sites 1221
M Subtype IIP or IIA. Require methylated target 257
H
Symmetric or asymmetric target. Similar to Type I gene 
structure
~ 50
T
Symmetric or asymmetric target. R genes are 
heterodimers
25
B Cleaves both sides of target on both strands 16
E Two targets; one cleaved, one an effector 12
F Two targets, both cleaved coordinately 8
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